Document:

Registration RIghts Agreement, dated February 27, 2008

 Exhibit 4.2 
 REGISTRATION RIGHTS AGREEMENT 
 REGISTRATION RIGHTS AGREEMENT (this
“Agreement”), dated as of February 27, 2008, by and among Verenium Corporation, a Delaware corporation, with headquarters located at 55 Cambridge Parkway, Cambridge, Massachusetts 02142 (the “Company”), and the
undersigned buyers (each, a “Buyer”, and collectively, the “Buyers”). 
 WHEREAS: 
 A. In connection with the Securities Purchase Agreement by and among the parties hereto of even date herewith (the “Securities Purchase
Agreement”) and the Senior Notes Exchange Agreements entered into by the Company with certain of the Buyers of even date herewith (the “Exchange Agreements”), the Company has agreed, upon the terms and subject to the
conditions set forth in the Securities Purchase Agreement and the Exchange Agreements, to issue and sell to each Buyer (i) senior convertible notes of the Company (the “Notes”), which will, among other things, be convertible
into shares of the Company’s common stock, $0.001 par value per share (the “Common Stock”, as converted, the “Conversion Shares”) in accordance with the terms of the Notes, and (ii) warrants (the
“Warrants”), which will be exercisable to purchase shares of Common Stock (as exercised collectively, the “Warrant Shares”). 
 B. The Notes bear interest, which at the option of the Company, subject to certain conditions, may be paid in shares of Common Stock (the “Interest Shares”). 
 C. To induce the Buyers to execute and deliver the Securities Purchase Agreement, the Company has agreed to provide certain registration rights under the
Securities Act of 1933, as amended, and the rules and regulations thereunder, or any similar successor statute (collectively, the “1933 Act”), and applicable state securities laws. 
 NOW, THEREFORE, in consideration of the premises and the mutual covenants contained herein and other good and valuable consideration, the receipt
and sufficiency of which are hereby acknowledged, the Company and each of the Buyers hereby agree as follows: 
 1. Definitions.

 Capitalized terms used herein and not otherwise defined herein shall have the respective meanings set forth in the Securities Purchase
Agreement. As used in this Agreement, the following terms shall have the following meanings: 
 a. “Additional Effective
Date” means each date any Additional Registration Statement is declared effective by the SEC. 
 b. “Additional
Effectiveness Deadline” means the earlier of the date which is (i) in the event that such Additional Registration Statement is not subject to a review by the SEC, ninety (90) calendar days after such Additional Filing Date or
(ii) in the event that such Additional Registration Statement is subject to a review by the SEC, one-hundred and twenty (120) calendar days after such Additional Filing Date. 

 c. “Additional Filing Date” means the date on which any Additional Registration
Statement is filed with the SEC. 
 d. “Additional Filing Deadline” means if Cutback Shares are required to be included in
any Additional Registration Statement, the date that is the later of (i) the date sixty (60) days after the date substantially all of the Registrable Securities registered under the immediately preceding Registration Statement are sold and
(ii) the date six (6) months from the Initial Effective Date or the immediately preceding Additional Effective Date, as applicable, or, if earlier than the date determined pursuant to clauses (i) or (ii) above, sixty
(60) days from the date the SEC first permits the Company to file the Additional Registration Statement for the applicable Cutback Securities. 
 e. “Additional Registrable Securities” means (i) any Cutback Shares not previously included on a Registration Statement and (ii) any capital stock of the Company issued or issuable with
respect to the Notes, the Conversion Shares, the Interest Shares, the Warrant Shares, the Warrants or Cutback Shares, as applicable, as a result of any stock split, stock dividend, recapitalization, exchange or similar event or otherwise, without
regard to any limitations on conversions of the Notes. 
 f. “Additional Registration Statement” means a registration
statement or registration statements of the Company filed under the 1933 Act covering any Additional Registrable Securities. 
 g.
“Additional Required Registration Amount” means any Cutback Shares not previously included on a Registration Statement, all subject to adjustment as provided in Section 2(f), without regard to any limitations on conversions of
the Notes. 
 h. “Business Day” means any day other than Saturday, Sunday or any other day on which commercial banks in the
City of New York are authorized or required by law to remain closed. 
 i. “Closing Date” shall have the meaning set forth
in the Securities Purchase Agreement. 
 j. “Cutback Shares” means any of the Initial Required Registration Amount (without
regard to clause (II) in the definition thereof) of Registrable Securities not included in all Registration Statements previously declared effective hereunder as a result of a limitation on the maximum number of shares of Common Stock of the Company
permitted to be registered by the staff of the SEC pursuant to Rule 415. 
 k. “Effective Date” means the Initial Effective
Date and any Additional Effective Date, as applicable. 
 l. “Effectiveness Deadline” means the Initial Effectiveness
Deadline and any Additional Effectiveness Deadline, as applicable. 
  

 2 

 m. “Filing Date” means the Initial Filing Date and any Additional Filing Date, as
applicable. 
 n. “Filing Deadline” means the Initial Filing Deadline and any Additional Filing Deadline, as applicable.

 o. “Filing Requirement” shall mean that the Company has filed all required reports under Section 13 or 15(d) of the
Exchange Act during the preceding 12 months period, other than Form 8-K reports. 
 p. “Initial Effective Date” means the
date the Initial Registration Statement has been declared effective by the SEC. 
 q. “Initial Effectiveness Deadline”
means the earlier of the date which is (i) in the event that the Initial Registration Statement is not subject to a review by the SEC, ninety (90) calendar days after the Closing Date or (ii) in the event that the Initial Registration
Statement is subject to a review by the SEC, one-hundred and twenty (120) calendar days after the Closing Date. 
 r. “Initial
Filing Date” means the date the Initial Registration Statement has been filed with the SEC. 
 s. “Initial Filing
Deadline” means the date forty-five (45) calendar days after the Closing Date. 
 t. “Initial Registrable
Securities” means (i) the Conversion Shares issued or issuable upon conversion and/or redemption of the Notes, (ii) the Interest Shares issued or issuable with respect to the Notes, (iii) the Warrant Shares issued or issuable
upon exercise of the Warrants, and (iv) any capital stock of the Company issued or issuable with respect to the Conversion Shares, the Notes, the Warrant Shares, the Warrants and the Interest Shares as a result of any stock split, stock
dividend, recapitalization, exchange or similar event or otherwise, without regard to any limitations on conversions or redemptions of the Notes. 
 u. “Initial Registration Statement” means a registration statement or registration statements of the Company filed under the 1933 Act covering the Initial Registrable Securities. 
 v. “Initial Required Registration Amount” means (I) 47,807,018 shares of Common Stock comprised of in part, (i) the number of
Conversion Shares issued and issuable pursuant to the Notes as of the Trading Day (as defined in the Notes) immediately preceding the applicable date of determination, (ii) the number of Warrant Shares issued or issuable pursuant to the
Warrants, as of the Trading Day immediately preceding the applicable date of determination and (iii) the number of Interest Shares issued or issuable with respect to the Notes as of the Trading Day immediately preceding the applicable date of
determination assuming that the Notes remain outstanding through the Maturity Date (as defined in the Notes), each subject to adjustment as provided in Section 2(f), without regard to any limitations on conversions or redemptions of the Notes
or (II) such other amount as may be required by the staff of the SEC pursuant to Rule 415 with any cutback applied pro rata to all holders of Registrable Securities. 
  

 3 

 w. “Investor” means a Buyer or any transferee or assignee thereof to whom a Buyer
assigns its rights as a holder of Registrable Securities under this Agreement and who agrees to become bound by the provisions of this Agreement in accordance with Section 9 and any transferee or assignee thereof to whom a transferee or
assignee assigns its rights as a holder of Registrable Securities under this Agreement and who agrees to become bound by the provisions of this Agreement in accordance with Section 9. 
 x. “Person” means an individual, a limited liability company, a partnership, a joint venture, a corporation, a trust, an unincorporated
organization and a government or any department or agency thereof. 
 y. “register,” “registered,” and
“registration” refer to a registration effected by preparing and filing one or more Registration Statements (as defined below) in compliance with the 1933 Act and pursuant to Rule 415 and the declaration or ordering of effectiveness
of such Registration Statement(s) by the SEC. 
 z. “Registrable Securities” means the Initial Registrable Securities and
the Additional Registrable Securities; provided, however, that a Security shall cease to be a Registrable Security upon the earliest to occur of the following: (i) a Registration Statement registering such Security under the 1933 Act has been
declared or becomes effective and such security has been sold or otherwise transferred by the holder thereof pursuant to and in a manner contemplated by such effective Registration Statement, (ii) such Security is sold pursuant to Rule 144
under circumstances in which any legend borne by such Security relating to restrictions on transferability thereof, under the 1933 Act or otherwise, is removed by the Company, (iii) such Security is eligible to be sold pursuant to Rule 144
without condition or restriction, or (iv) such Security shall cease to be outstanding. 
 aa. “Registration Statement”
means the Initial Registration Statement and any Additional Registration Statement, as applicable. 
 bb. “Required
Holders” means Investors that hold at least 66.67% of the Registrable Securities. 
 cc. “Rule 144 Period” shall
mean the period from the six-month anniversary of the Closing Date until the one-year anniversary of the Closing Date. 
 dd. “Rule
415” means Rule 415 promulgated under the 1933 Act or any successor rule providing for offering securities on a continuous or delayed basis. 
 ee. “SEC” means the United States Securities and Exchange Commission. 
 2.
Registration. 
 a. Initial Mandatory Registration. The Company shall prepare, and, as soon as practicable but in no event
later than the Initial Filing Deadline, file with the SEC the 

  

 4 

 
Initial Registration Statement on Form S-3 covering the resale of at least the number of shares of Common Stock equal to the Initial Required Registration
Amount determined as of date the Registration Statement is initially filed with the SEC. In the event that Form S-3 is unavailable for such a registration, the Company shall use such other form as is available for such a registration on another form
reasonably acceptable to the Required Holders, subject to the provisions of Section 2(e). The Initial Registration Statement prepared pursuant hereto shall register for resale that number of shares of Common Stock equal to the Initial Required
Registration Amount determined as of the date such Initial Registration Statement is initially filed with the SEC. The Initial Registration Statement shall contain (except if otherwise directed by the Required Holders) the “Selling
Stockholders” and “Plan of Distribution” sections for the Investors in substantially the forms attached hereto as Exhibit B and Exhibit C, respectively and any information provided by the Investors in a
completed selling stockholder questionnaire in substantially the form attached hereto as Exhibit D. The Company shall use its reasonable best efforts to have the Initial Registration Statement declared effective by the SEC as soon as
practicable, but in no event later than the Initial Effectiveness Deadline. To the extent the staff of the SEC requires that the number of Registrable Securities registered for resale on the Initial Registration Statement be reduced, the Company
shall reduce the number of Registrable Securities (reducing first from the pool of Conversion Shares (or should an Investor request otherwise, such other Registrable Securities of such Investor that such Investor shall specify)) so registered on
such Registration Statement to one-third (1/3) of the Company’s non-affiliate public float on the Closing Date, and will file one or more Additional Registration Statements on Form S-3 covering the excess shares, as described in
Section 2(b). By 9:30 a.m. New York time on the Business Day following the Initial Effective Date, the Company shall file with the SEC in accordance with Rule 424 under the 1933 Act the final prospectus to be used in connection with sales
pursuant to such Initial Registration Statement. 
 b. Additional Mandatory Registrations. The Company shall prepare, and, as soon as
practicable but in no event later than the Additional Filing Deadline, file with the SEC a Registration Statement on Form S-3 covering the resale of all of the Additional Registrable Securities not previously registered on a Registration Statement
hereunder. To the extent the staff of the SEC does not permit the Additional Required Registration Amount to be registered on an Additional Registration Statement, the Company shall file Additional Registration Statements successively trying to
register on each such Additional Registration Statement the maximum number of remaining Additional Registrable Securities until the Additional Required Registration Amount has been registered with the SEC. In the event that Form S-3 is unavailable
for such a registration, the Company shall use such other form as is available for such a registration on a form reasonably acceptable to the Required Holders, subject to the provisions of Section 2(e). Each Additional Registration Statement
prepared pursuant hereto shall register for resale that number of shares of Common Stock equal to the Additional Required Registration Amount determined as of the date such Additional Registration Statement is initially filed with the SEC (subject
to reductions to the extent the staff of the SEC requires that the number of Additional Registrable Securities registered for resale on such Additional Registration Statement be reduced). Each Additional Registration Statement shall contain (except
if otherwise directed by the Required Holders) the “Selling Stockholders” and “Plan of Distribution” sections in substantially the form attached hereto as Exhibit B. The Company shall use its reasonable best
efforts to have each Additional Registration Statement declared effective by the SEC as soon as practicable, but in no event later than the Additional Effectiveness 
  

 5 

 
Deadline for such Additional Registration Statement. By 9:30 am on the Business Day following the Additional Effective Date for each Additional Registration
Statement, the Company shall file with the SEC in accordance with Rule 424 under the 1933 Act the final prospectus to be used in connection with sales pursuant to such Additional Registration Statement. 
 c. Allocation of Registrable Securities. The initial number of Registrable Securities included in any Registration Statement and any increase or
decrease in the number of Registrable Securities included therein shall be allocated pro rata among the Investors based on the number of Registrable Securities held by each Investor at the time the Registration Statement covering such initial number
of Registrable Securities or increase or decrease thereof is declared effective by the SEC. In the event that an Investor sells or otherwise transfers any of such Investor’s Registrable Securities, each transferee shall be allocated a pro rata
portion of the then remaining number of Registrable Securities included in such Registration Statement for such transferor. Any shares of Common Stock included in a Registration Statement and which remain allocated to any Person which ceases to hold
any Registrable Securities covered by such Registration Statement shall be allocated to the remaining Investors, pro rata based on the number of Registrable Securities then held by such Investors which are covered by such Registration Statement. In
no event shall the Company include any securities other than Registrable Securities on any Registration Statement without the prior written consent of the Required Holders. 
 d. Legal Counsel. Subject to Section 5 hereof, the Required Holders shall have the right to select one legal counsel to review and oversee
any registration pursuant to this Section 2 (“Legal Counsel”), which shall be Paul, Hastings, Janofsky & Walker, LLP or such other counsel as thereafter designated by the Required Holders. The Company and Legal Counsel
shall reasonably cooperate with each other in performing the Company’s obligations under this Agreement. 
 e. Ineligibility for
Form S-3. In the event that Form S-3 is not available for the registration of the resale of Registrable Securities hereunder, the Company shall (i) register the resale of the Registrable Securities on a form reasonably acceptable to the
Required Holders and (ii) undertake to register the Registrable Securities on Form S-3 as soon as the use of such form for such purpose is permitted, provided that the Company shall maintain the effectiveness of the Registration Statement then
in effect until such time as a Registration Statement on Form S-3 covering the Registrable Securities has been declared effective by the SEC. 
 f. Sufficient Number of Shares Registered. In the event the number of shares available under a Registration Statement filed pursuant to Section 2(a) or 2(b) is insufficient to cover all of the Registrable Securities required to
be covered by such Registration Statement or an Investor’s allocated portion of the Registrable Securities pursuant to Section 2(b), the Company shall, if the Registration Statement has not been declared effective, amend the applicable
Registration Statement, or, in all other cases, file a new Registration Statement (on the short form available therefor, if applicable), so as to cover at least the Initial Required Registration Amount or the Additional Required Registration Amount,
as applicable to the applicable Registration Statement, as of the Trading Day immediately preceding the date of the 

  

 6 

 
filing of such amendment or new Registration Statement, in each case, as soon as practicable, but in any event not later than thirty (30) days after the
necessity therefor arises. The Company shall use its reasonable best efforts to cause such amendment or new Registration Statement to become effective as soon as practicable following the filing thereof. For purposes of the foregoing provision, the
number of shares available under a Registration Statement shall be deemed “insufficient to cover all of the Registrable Securities” if at any time the number of shares of Common Stock available for resale under the Registration Statement
is less than the product determined by multiplying (i) the Initial Required Registration Amount or Additional Required Registration Amount, as applicable to the applicable Registration Statement, as of such time by (ii) 0.90. The
calculation set forth in the foregoing sentence shall be made without regard to any limitations on the conversion of the Notes and such calculation shall assume that the Notes are then convertible into shares of Common Stock at the then prevailing
Conversion Rate (as defined in the Notes). 
 g. Effect of Failure to File and Obtain and Maintain Effectiveness of Registration
Statement. If (i) a Registration Statement covering all of the Registrable Securities required to be covered thereby and required to be filed by the Company pursuant to this Agreement is (A) not filed with the SEC on or before the
respective Filing Deadline (a “Filing Failure”) or (B) not declared effective by the SEC on or before the respective Effectiveness Deadline (an “Effectiveness Failure”) or (ii) on any day after the
Effective Date sales of all of the Registrable Securities required to be covered by such Registration Statement cannot be made (other than during an Allowable Grace Period (as defined in Section 3(r)) pursuant to such Registration Statement or
otherwise (including, without limitation, because of a failure to keep such Registration Statement effective, to disclose such information as is necessary for sales to be made pursuant to such Registration Statement or to register a sufficient
number of shares of Common Stock or to maintain the listing of the shares of Common Stock) (a “Maintenance Failure”) then, as partial relief for the damages to any Investor by reason of any such delay in or reduction of its ability
to sell the underlying shares of Common Stock (which remedy shall not be exclusive of any other remedies available at law or in equity), the Company shall pay to each Investor relating to such Registration Statement an amount in cash equal to one
percent (1.0%) of the aggregate Purchase Price (as such term is defined in the Securities Purchase Agreement) of such Investor’s Registrable Securities included in such Registration Statement on the day of the respective Filing Failure,
Effectiveness Failure or Maintenance Failure for the first thirty (30) days during which such Filing Failure, Effectiveness Failure or Maintenance Failure continues (pro rated for any period totaling less than thirty (30) days), and
thereafter two percent (2.0%) of the aggregate Purchase Price (as such term is defined in the Securities Purchase Agreement) of such Investor’s Registrable Securities included in such Registration Statement for each ensuing thirty
(30) day period during which such Filing Failure, Effectiveness Failure or Maintenance Failure continues (pro rated for any period totaling less than thirty (30) days), subject to a maximum penalty of ten percent (10%) of the
aggregate Purchase Price (as such term is defined in the Securities Purchase Agreement) paid by such Investor pursuant to the Securities Purchase Agreement for all Registration Delay Payments (as defined below) payable to an Investor under this
Agreement. The payments to which an Investor shall be entitled pursuant to this Section 2(f) are referred to herein as “Registration Delay Payments.” Registration Delay Payments shall be paid on the earlier of (I) the last
day of the calendar month during which such Registration Delay Payments are incurred and (II) the third Business Day after the event or failure giving rise to the Registration Delay Payments is cured. In the event the Company fails to make
Registration Delay Payments in a timely manner, such Registration Delay Payments shall bear interest at the rate of one percent (1.0%) per month (prorated for partial months) until paid in full. 
  

 7 

 h. Effect of Failure to Timely File Required Reports. If at any time during the Rule 144 Period,
the Company has not had declared effective a Registration Statement covering all Registrable Securities, and the Company does not meet the Filing Requirement as of the determination date, it shall pay to each Investor an amount in cash equal to one
percent (1.0%) of the aggregate Purchase Price (as such term is defined in the Securities Purchase Agreement) of such Investor’s Registrable Securities on the date of such failure for the first thirty (30) days during which such
failure continues (prorated for any period totaling less than thirty (30) days) and thereafter an additional (1.0%) of the aggregate Purchase Price (as such term is defined in the Securities Purchase Agreement) of such Investor’s
Registrable Securities for each ensuing thirty (30) day period (prorated for any period totaling less than thirty (30) days) until the earlier of (i) such time as all of such Investor’s Registrable Securities have been registered
pursuant to an effective Registration Statement and (ii) the expiration of the Rule 144 Period. 
 i. Neither the Company nor any
Subsidiary (as defined in the Securities Purchase Agreement) nor affiliate thereof shall identify any Buyer as an underwriter in any public disclosure or filing with the SEC or any Principal Market (as defined in the Securities Purchase Agreement)
without the prior written consent of such Buyer or any Trading Market (as defined in the Securities Purchase Agreement) and any Buyer being deemed an underwriter by the SEC shall not relieve the Company of any obligations it has under this Agreement
or any other Transaction Document (as defined in the Securities Purchase Agreement) provided, however, that the foregoing shall not prohibit the Company from including the disclosure found in the “Plan of Distribution” section attached
hereto as Exhibit B in the Registration Statement. 
 3. Related Obligations. 
 At such time as the Company is obligated to file a Registration Statement with the SEC pursuant to Section 2(a), 2(b), 2(e) or 2(f), the Company will
use its reasonable best efforts to effect the registration of the Registrable Securities in accordance with the intended method of disposition thereof and, pursuant thereto, the Company shall have the following obligations: 
 a. The Company shall submit to the SEC, within two (2) Business Days after the Company learns that no review of a particular Registration Statement
will be made by the staff of the SEC or that the staff has no further comments on a particular Registration Statement, as the case may be, a request for acceleration of effectiveness of such Registration Statement to a time and date not later than
48 hours after the submission of such request. The Company shall keep each Registration Statement effective pursuant to Rule 415 at all times until the earlier of (i) the date as of which the Investors may sell all of the Registrable Securities
covered by such Registration Statement without condition or restriction pursuant to Rule 144 (or any successor thereto) promulgated under the 1933 Act, (ii) the date on which the Investors shall have sold all of the Registrable Securities
covered by such Registration Statement, or (iii) the date when the securities covered by the Registration Statement are no longer Registrable Securities as defined herein (the “Registration Period”). The Company shall ensure
that each Registration Statement (including any amendments or supplements thereto and prospectuses 

  

 8 

 
contained therein) shall not contain any untrue statement of a material fact or omit to state a material fact required to be stated therein, or necessary to
make the statements therein (in the case of prospectuses, in the light of the circumstances in which they were made) not misleading. 
 b.
The Company shall prepare and file with the SEC such amendments (including post-effective amendments) and supplements to a Registration Statement and the prospectus used in connection with such Registration Statement, which prospectus is to be filed
pursuant to Rule 424 promulgated under the 1933 Act, as may be necessary to keep such Registration Statement effective at all times during the Registration Period, and, during such period, comply with the provisions of the 1933 Act with respect to
the disposition of all Registrable Securities of the Company covered by such Registration Statement until such time as all of such Registrable Securities shall have been disposed of in accordance with the intended methods of disposition by the
seller or sellers thereof as set forth in such Registration Statement. In the case of amendments and supplements to a Registration Statement which are required to be filed pursuant to this Agreement (including pursuant to this Section 3(b)) by
reason of the Company filing a report on Form 10-Q, Form 10-K or any analogous report under the Securities Exchange Act of 1934, as amended (the “1934 Act”), the Company shall have incorporated such report by reference into such
Registration Statement, if applicable, or shall file such amendments or supplements with the SEC on the same day on which the 1934 Act report is filed which created the requirement for the Company to amend or supplement such Registration Statement.

 c. The Company shall (A) permit Legal Counsel to review and comment upon (i) a Registration Statement at least five
(5) Business Days prior to its filing with the SEC and (ii) all amendments and supplements to all Registration Statements (except for any reports filed under the 1934 Act which may be deemed to supplement or amend the Registration
Statement, so long as such report was not filed solely for such purpose) within a reasonable number of days prior to their filing with the SEC, and (B) not file any Registration Statement or amendment or supplement thereto in a form to which
Legal Counsel reasonably and timely objects. The Company shall furnish to Legal Counsel, without charge, (i) copies of any correspondence from the SEC or the staff of the SEC to the Company or its representatives relating to any Registration
Statement, (ii) promptly after the same is prepared and filed with the SEC, one copy of any Registration Statement and any amendment(s) thereto, including financial statements and schedules, all documents incorporated therein by reference, if
requested by an Investor, and all exhibits (unless such Registration Statement is available on EDGAR) and (iii) upon the effectiveness of any Registration Statement, one copy of the prospectus included in such Registration Statement and all
amendments and supplements thereto. The Company shall reasonably cooperate with Legal Counsel in performing the Company’s obligations pursuant to this Section 3. 
 d. The Company shall furnish each Investor whose Registrable Securities are included in any Registration Statement, without charge, (i) promptly
after the same is prepared and filed with the SEC, at least one copy of such Registration Statement and any amendment(s) thereto, including financial statements and schedules, all documents incorporated therein by reference, if requested by an
Investor, all exhibits and each preliminary prospectus (unless such Registration Statement is available on EDGAR), (ii) upon the effectiveness of any Registration Statement, ten (10) copies of the prospectus included in such Registration
Statement and all amendments and supplements thereto (unless such amendments and supplements are 

  

 9 

 
available on EDGAR) and (iii) such other documents, including copies of the foregoing (regardless of whether such documents are available upon EDGAR)
and any preliminary or final prospectus, as such Investor may reasonably request from time to time in order to facilitate the disposition of the Registrable Securities owned by such Investor. 
 e. The Company shall use its reasonable best efforts to (i) register and qualify, unless an exemption from registration and qualification applies,
the resale by Investors of the Registrable Securities covered by a Registration Statement under such other securities or “blue sky” laws of all applicable jurisdictions in the United States, (ii) prepare and file in those
jurisdictions, such amendments (including post-effective amendments) and supplements to such registrations and qualifications as may be necessary to maintain the effectiveness thereof during the Registration Period, (iii) take such other
actions as may be reasonably necessary to maintain such registrations and qualifications in effect at all times during the Registration Period, and (iv) take all other actions reasonably necessary or advisable to qualify the Registrable
Securities for sale in such jurisdictions; provided, however, that the Company shall not be required in connection therewith or as a condition thereto to (x) qualify to do business in any jurisdiction where it would not otherwise
be required to qualify but for this Section 3(e), (y) subject itself to general taxation in any such jurisdiction, or (z) file a general consent to service of process in any such jurisdiction. The Company shall promptly notify Legal
Counsel and each Investor who holds Registrable Securities of the receipt by the Company of any notification with respect to the suspension of the registration or qualification of any of the Registrable Securities for sale under the securities or
“blue sky” laws of any jurisdiction in the United States or its receipt of notice of the initiation or threatening of any proceeding for such purpose. 
 f. The Company shall notify Legal Counsel and each Investor in writing of the happening of any event, as promptly as practicable after becoming aware of such event, as a result of which the prospectus included in a
Registration Statement, as then in effect, includes an untrue statement of a material fact or omission to state a material fact required to be stated therein or necessary to make the statements therein, in the light of the circumstances under which
they were made, not misleading (provided that in no event shall such notice contain any material, nonpublic information), and, subject to Section 3(r), promptly prepare a supplement or amendment to such Registration Statement to correct such
untrue statement or omission, and deliver ten (10) copies of such supplement or amendment to Legal Counsel and each Investor (or such other number of copies as Legal Counsel or such Investor may reasonably request) (unless such supplements or
amendments are available on EDGAR). The Company shall also promptly notify Legal Counsel and each Investor in writing (i) when a prospectus or any prospectus supplement or post-effective amendment has been filed, and when a Registration
Statement or any post-effective amendment has become effective (notification of such effectiveness shall be delivered to Legal Counsel and each Investor by facsimile no later than the next Business Day of such effectiveness and by overnight mail),
(ii) of any request by the SEC for amendments or supplements to a Registration Statement or related prospectus or related information, and (iii) of the Company’s reasonable determination that a post-effective amendment to a
Registration Statement would be appropriate. 
 g. The Company shall use its reasonable best efforts to prevent the issuance of any stop
order or other suspension of effectiveness of a Registration Statement, or the suspension of the qualification of any of the Registrable Securities for sale in any jurisdiction 

  

 10 

 
and, if such an order or suspension is issued, to obtain the withdrawal of such order or suspension at the earliest possible moment and to notify Legal
Counsel and each Investor who holds Registrable Securities being sold of the issuance of such order and the resolution thereof or its receipt of notice of the initiation or threat of any proceeding for such purpose. 
 h. If any Investor is deemed to be, alleged to be or reasonably believes it may be deemed or alleged to be, an underwriter or is required under
applicable securities law to be described in the Registration Statement as an underwriter of Registrable Securities, at the reasonable request of such Investor, the Company shall furnish to such Investor, on the date of the effectiveness of the
Registration Statement and thereafter from time to time on such dates as an Investor may reasonably request (i) a letter, dated such date, from the Company’s independent certified public accountants in form and substance as is customarily
given by independent certified public accountants to underwriters in an underwritten public offering, addressed to the applicable Investors, and (ii) an opinion, dated as of such date, of counsel representing the Company for purposes of such
Registration Statement, in form, scope and substance as is customarily given in an underwritten public offering, addressed to the applicable Investors. 
 i. If any Investor is deemed to be, alleged to be or reasonably believes it may be deemed or alleged to be, an underwriter or is required under applicable securities law to be described in the Registration Statement
as an underwriter of Registrable Securities, upon the request of such Investor, the Company shall make available for inspection by (i) such Investor, (ii) Legal Counsel and (iii) one firm of accountants or other agents retained by the
Investors (collectively, the “Inspectors”), all pertinent financial and other records, and pertinent corporate documents and properties of the Company (collectively, the “Records”), as shall be reasonably deemed
necessary by each Inspector, and cause the Company’s officers, directors and employees to supply all information which any Inspector may reasonably request; provided, however, that each Inspector shall agree to hold in strict confidence and
shall not make any disclosure (except to the other Inspectors) or use of any Record or other information which the Company determines in good faith to be confidential, and of which determination the Inspectors are so notified, unless (a) the
disclosure of such Records is necessary to avoid or correct a misstatement or omission in any Registration Statement or is otherwise required under the 1933 Act, (b) the release of such Records is ordered pursuant to a final, non-appealable
subpoena or order from a court or government body of competent jurisdiction, or (c) the information in such Records has been made generally available to the public other than by disclosure in violation of this or any other Transaction Document.
Each Investor agrees that it shall, upon learning that disclosure of such Records is sought in or by a court or governmental body of competent jurisdiction or through other means, give prompt notice to the Company and allow the Company, at its
expense, to undertake appropriate action to prevent disclosure of, or to obtain a protective order for, the Records deemed confidential. Nothing herein (or in any other confidentiality agreement between the Company and any Investor) shall be deemed
to limit the Investors’ ability to sell Registrable Securities in a manner which is otherwise consistent with applicable laws and regulations. 
 j. The Company shall hold in confidence and not make any disclosure of information (other than information provided to the Company by an Investor pursuant to Section 4(a)) concerning an Investor provided to the
Company unless (i) disclosure of such information is necessary to comply with federal or state securities laws or the rules of any exchange or other market in which the Company’s securities are then traded, listed or quoted, (ii) the
disclosure of 

  

 11 

 
such information is necessary to avoid or correct a misstatement or omission in any Registration Statement, (iii) the release of such information is
ordered pursuant to a subpoena or other final, non-appealable order from a court or governmental body of competent jurisdiction or (iv) such information has been made generally available to the public other than by disclosure in violation of
this Agreement, any other agreement to which the Company is a party, or, to the Company’s knowledge, any other agreement. The Company agrees that it shall, upon learning that disclosure of such information concerning an Investor is sought in or
by a court or governmental body of competent jurisdiction or through other means, give prompt written notice to such Investor and allow such Investor, at the Investor’s expense, to undertake appropriate action to prevent disclosure of, or to
obtain a protective order for, such information. 
 k. The Company shall use its reasonable best efforts either to (i) cause all of the
Registrable Securities covered by a Registration Statement to be listed on each securities exchange on which securities of the same class or series issued by the Company are then listed, if any, if the listing of such Registrable Securities is then
permitted under the rules of such exchange, or (ii) secure designation and quotation of all of the Registrable Securities covered by a Registration Statement on The NASDAQ Global Market or (iii) if, despite the Company’s reasonable
best efforts to satisfy, the preceding clauses (i) and (ii) the Company is unsuccessful in satisfying the preceding clauses (i) and (ii), to secure the inclusion for quotation on the The New York Stock Exchange, The NASDAQ Capital
Market or the American Stock Exchange for such Registrable Securities and, without limiting the generality of the foregoing, to use its reasonable best efforts to arrange for at least two market makers to register with the Financial Industry
Regulatory Authority as such with respect to such Registrable Securities. The Company shall pay all fees and expenses in connection with satisfying its obligation under this Section 3(k). 
 l. The Company shall cooperate with the Investors who hold Registrable Securities being offered and, to the extent applicable, facilitate the timely
preparation and delivery of certificates (not bearing any restrictive legend) representing the Registrable Securities to be offered pursuant to a Registration Statement and enable such certificates to be in such denominations or amounts, as the case
may be, as the Investors may reasonably request and registered in such names as the Investors may request. 
 m. If requested by an
Investor, the Company shall (i) as soon as practicable incorporate in a prospectus supplement or post-effective amendment such information as an Investor reasonably requests to be included in the Plan of Distribution or Selling Stockholder
sections relating to the sale and distribution of Registrable Securities, including, without limitation, information with respect to the number of Registrable Securities being offered or sold, the purchase price being paid therefor and any other
terms of the offering of the Registrable Securities to be sold in such offering; (ii) as soon as practicable make all required filings of such prospectus supplement or post-effective amendment after being notified of the matters to be
incorporated in such prospectus supplement or post-effective amendment; and (iii) as soon as practicable, supplement or make amendments to any Registration Statement if reasonably requested by an Investor holding any Registrable Securities.

 n. The Company shall use its reasonable best efforts to cause the Registrable Securities covered by a Registration Statement to be
registered with or approved by such other governmental agencies or authorities as may be necessary to consummate the disposition of such Registrable Securities. 
  

 12 

 o. The Company shall make generally available to its security holders as soon as practical, but not
later than ninety (90) days after the close of the period covered thereby, an earnings statement (in form complying with, and in the manner provided by, the provisions of Rule 158 under the 1933 Act) covering a twelve-month period beginning not
later than the first day of the Company’s fiscal quarter next following the effective date of a Registration Statement. 
 p. The
Company shall otherwise use its reasonable best efforts to comply with all applicable rules and regulations of the SEC in connection with any registration hereunder. 
 q. Within five (5) Business Days after a Registration Statement which covers Registrable Securities is ordered effective by the SEC, the Company shall deliver, and shall cause legal counsel for the Company (which
may be the General Counsel of the Company) to deliver, to the transfer agent for such Registrable Securities (with copies to the Investors whose Registrable Securities are included in such Registration Statement) confirmation that such Registration
Statement has been declared effective by the SEC in the form attached hereto as Exhibit A. 
 r. Notwithstanding anything to the
contrary herein, at any time after any Effective Date, the Company may delay the disclosure of material, non-public information concerning the Company the disclosure of which at the time is not, in the good faith opinion of the Board of Directors of
the Company, in the best interest of the Company otherwise required or otherwise render the Registration Statement unavailable for sales to be effected thereunder (a “Grace Period”); provided, that the Company shall promptly
(i) notify the Investors in writing of the existence of material, non-public information giving rise to a Grace Period (provided that in each notice the Company will not disclose the content of such material, non-public information to the
Investors) and the date on which the Grace Period will begin on the first day that the effectiveness of the Registration Statement is suspended, and (ii) notify the Investors in writing of the date on which the Grace Period ends; and, provided
further, that no Grace Period shall exceed twenty-five (25) consecutive days and during any three hundred sixty five (365) day period such Grace Periods shall not exceed an aggregate of sixty (60) days and the first day of any Grace
Period must be at least five (5) Trading Days after the last day of any prior Grace Period (each, an “Allowable Grace Period”). For purposes of determining the length of a Grace Period above, the Grace Period shall begin on and
include the date the Investors receive the notice referred to in clause (i) and shall end on and include the later of the date the Investors receive the notice referred to in clause (ii) and the date referred to in such notice. The
provisions of Section 3(g) hereof shall not be applicable during the period of any Allowable Grace Period. Upon expiration of the Grace Period, the Company shall again be bound by the first sentence of Section 3(f) with respect to the
information giving rise thereto unless such material, non-public information is no longer applicable. Notwithstanding anything to the contrary, the Company shall cause its transfer agent to deliver unlegended shares of Common Stock to a transferee
of an Investor in accordance with the terms of the Securities Purchase Agreement in connection with any sale of Registrable Securities with respect to which an Investor has entered into a contract for sale, and delivered a copy of the prospectus
included as part of the applicable Registration Statement (unless an exemption from such prospectus delivery requirement exists), prior to the Investor’s receipt of the notice of a Grace Period and for which the Investor has not yet settled.

  

 13 

 s. If NASDR Rule 2710 requires any broker-dealer to make a filing prior to executing a sale by a Holder,
the Company shall (i) make an Issuer Filing with the NASDR, Inc. Corporate Financing Department pursuant to proposed NASDR Rule 2710(b)(10)(A)(i), (ii) respond within five Trading Days to any comments received from NASDR in connection
therewith, and (iii) pay the filing fee required in connection therewith. 
 4. Obligations of the Investors. 
 a. At least five (5) Business Days prior to the first anticipated filing date of a Registration Statement, the Company shall send each Investor a
selling stockholder questionnaire in substantially the form attached hereto as Exhibit D. It shall be a condition precedent to the obligations of the Company to complete the registration pursuant to this Agreement with respect to the
Registrable Securities of a particular Investor that such Investor shall furnish to the Company such information regarding itself, the Registrable Securities held by it and the intended method of disposition of the Registrable Securities held by it
as shall be reasonably required to effect and maintain the effectiveness of the registration of such Registrable Securities within five (5) Business Days and such Investor shall execute such documents in connection with such registration as the
Company may reasonably request. 
 b. Each Investor, by such Investor’s acceptance of the Registrable Securities, agrees to cooperate
with the Company as reasonably requested by the Company in connection with the preparation and filing of any Registration Statement hereunder, unless such Investor has notified the Company in writing of such Investor’s election to exclude all
of such Investor’s Registrable Securities from such Registration Statement. 
 c. Each Investor agrees that, upon receipt of any notice
from the Company of the happening of any event of the kind described in Section 3(g) or the first sentence of Section 3(f), such Investor will immediately discontinue disposition of Registrable Securities pursuant to any Registration
Statement(s) covering such Registrable Securities until such Investor’s receipt of the copies of the supplemented or amended prospectus contemplated by Section 3(g) or the first sentence of Section 3(f) or receipt of notice that no
supplement or amendment is required. Notwithstanding anything to the contrary, the Company shall cause its transfer agent to deliver unlegended shares of Common Stock to a transferee of an Investor in accordance with the terms of the Securities
Purchase Agreement in connection with any sale of Registrable Securities with respect to which an Investor has entered into a contract for sale prior to the Investor’s receipt of a notice from the Company of the happening of any event of the
kind described in Section 3(g) or the first sentence of Section 3(f) and for which the Investor has not yet settled. 
 d. Each
Investor covenants and agrees that it will comply with the prospectus delivery requirements of the 1933 Act as applicable to it or an exemption therefrom in connection with sales of Registrable Securities pursuant to the Registration Statement.

  

 14 

 5. Expenses of Registration. 
 All reasonable expenses, other than underwriting discounts and commissions, incurred in connection with registrations, filings or qualifications pursuant
to Sections 2 and 3, including, without limitation, all registration, listing and qualifications fees, printers and accounting fees, and fees and disbursements of counsel for the Company, shall be paid by the Company. The Company shall also
reimburse the Investors for the fees and disbursements of Legal Counsel in connection with registration, filing or qualification pursuant to Sections 2 and 3 of this Agreement which amount shall be limited to $5,000 for each such registration,
filing or qualification. 
 6. Indemnification. 
 In the event any Registrable Securities are included in a Registration Statement under this Agreement: 
 a.
To the fullest extent permitted by law, the Company will, and hereby does, indemnify, hold harmless and defend each Investor, the directors, officers, members, partners, employees, agents, representatives of, and each Person, if any, who controls
any Investor within the meaning of the 1933 Act or the 1934 Act (each, an “Indemnified Person”), against any losses, claims, damages, liabilities, judgments, fines, penalties, charges, costs, reasonable attorneys’ fees, amounts
paid in settlement or expenses, joint or several (collectively, “Claims”) incurred in investigating, preparing or defending any action, claim, suit, inquiry, proceeding, investigation or appeal taken from the foregoing by or before
any court or governmental, administrative or other regulatory agency, body or the SEC, whether pending or threatened, whether or not an indemnified party is or may be a party thereto (“Indemnified Damages”), to which any of them may
become subject insofar as such Claims (or actions or proceedings, whether commenced or threatened, in respect thereof) arise out of or are based upon: (i) any untrue statement or alleged untrue statement of a material fact in a Registration
Statement or any post-effective amendment thereto or in any filing made in connection with the qualification of the offering under the securities or other “blue sky” laws of any jurisdiction in which Registrable Securities are offered
(“Blue Sky Filing”), or the omission or alleged omission to state a material fact required to be stated therein or necessary to make the statements therein not misleading, (ii) any untrue statement or alleged untrue statement
of a material fact contained in any preliminary prospectus if used prior to the effective date of such Registration Statement, or contained in the final prospectus (as amended or supplemented, if the Company files any amendment thereof or supplement
thereto with the SEC) or the omission or alleged omission to state therein any material fact necessary to make the statements made therein, in the light of the circumstances under which the statements therein were made, not misleading,
(iii) any violation or alleged violation by the Company of the 1933 Act, the 1934 Act, any other law, including, without limitation, any state securities law, or any rule or regulation thereunder relating to the offer or sale of the Registrable
Securities pursuant to a Registration Statement or (iv) any breach by the Company of a representation, warranty or covenant contained in this Agreement (the matters in the foregoing clauses (i) through (iv) being, collectively,
“Violations”). Subject to Section 6(c), the Company shall reimburse the Indemnified Persons, promptly as such expenses are incurred and are due and payable, for any reasonable legal fees or other reasonable expenses incurred by
them in connection with investigating or defending any 

  

 15 

 
such Claim. Notwithstanding anything to the contrary contained herein, the indemnification agreement contained in this Section 6(a): (i) shall not
apply to a Claim by an Indemnified Person arising out of or based upon a Violation which occurs (A) in reliance upon and in conformity with information furnished in writing to the Company by such Indemnified Person expressly for use in
connection with the preparation of the Registration Statement (including any amendment thereto, any related prospectus, or any prospectus supplement) (which information provided by the Investors includes Exhibits B and C to this Agreement),
(B) failure by the Investor to comply with prospectus delivery requirements, if such prospectus, or any such amendment thereof or supplement thereto, was timely made available by the Company pursuant to Section 3(d), or (C) the use by
such Investor of an outdated or defective prospectus after the Company has notified such Investor in writing that the prospectus is outdated or defective and prior to the receipt by such Investor of an amended or supplemented prospectus, and
(ii) shall not apply to amounts paid in settlement of any Claim if such settlement is effected without the prior written consent of the Company, which consent shall not be unreasonably withheld or delayed. Such indemnity shall remain in full
force and effect regardless of any investigation made by or on behalf of the Indemnified Person and shall survive the transfer of the Registrable Securities by the Investors pursuant to Section 9. 
 b. In connection with any Registration Statement in which an Investor is participating, each such Investor agrees to severally and not jointly
indemnify, hold harmless and defend, to the same extent and in the same manner as is set forth in Section 6(a), the Company, each of its directors, each of its officers who signs the Registration Statement and each Person, if any, who controls
the Company within the meaning of the 1933 Act or the 1934 Act (each, an “Indemnified Party”), against any Claim or Indemnified Damages to which any of them may become subject, under the 1933 Act, the 1934 Act or otherwise, insofar
as such Claim or Indemnified Damages arise out of or are based upon any Violation, in each case to the extent, and only to the extent, that such Violation arises from the circumstances described in clauses (A) through (C) of
Section 6(a) above; and, subject to Section 6(c), such Investor shall reimburse the Indemnified Party, promptly as such expenses are incurred and are due and payable, for any legal fees or other reasonable expenses incurred by it in
connection with investigating or defending any such Claim; provided, however, that the indemnity agreement contained in this Section 6(b) and the agreement with respect to contribution contained in Section 7 shall not apply to amounts paid
in settlement of any Claim if such settlement is effected without the prior written consent of such Investor, which consent shall not be unreasonably withheld or delayed; provided, further, however, that the Investor shall be liable under this
Section 6(b) for only that amount of a Claim or Indemnified Damages as does not exceed the net proceeds to such Investor as a result of the sale of Registrable Securities pursuant to such Registration Statement. Such indemnity shall remain in
full force and effect regardless of any investigation made by or on behalf of such Indemnified Party and shall survive the transfer of the Registrable Securities by the Investors pursuant to Section 9. 
 c. Promptly after receipt by an Indemnified Person or Indemnified Party under this Section 6 of notice of the commencement of any action or
proceeding (including any governmental action or proceeding) involving a Claim, such Indemnified Person or Indemnified Party shall, if a Claim in respect thereof is to be made against any indemnifying party under this Section 6, deliver to the
indemnifying party a written notice of the commencement thereof, and the indemnifying party shall have the right to participate in, and, to the extent the indemnifying 

  

 16 

 
party so desires, jointly with any other indemnifying party similarly noticed, to assume control of the defense thereof with counsel mutually satisfactory to
the indemnifying party and the Indemnified Person or the Indemnified Party, who shall not, except with the consent of the indemnifying party, be counsel to the Indemnified Person or the Indemnified Party as the case may be; and after notice from the
indemnifying party of its election to assume the defense thereof, the indemnifying party shall not be liable to the Indemnified Party or Indemnified Person for any legal expenses of other counsel or other expenses incurred in connection with the
defense thereof; provided, however, that an Indemnified Person or Indemnified Party shall have the right to retain its own counsel with the reasonable fees and expenses of not more than one counsel for such Indemnified Person or
Indemnified Party to be paid by the indemnifying party, if, in the reasonable opinion of counsel retained by the indemnifying party, the representation by such counsel of the Indemnified Person or Indemnified Party and the indemnifying party would
likely represent a conflict of interest that would legally preclude such representation. In the case of an Indemnified Person, legal counsel referred to in the immediately preceding sentence shall be selected by the Investors holding at least 80%
interest of the Registrable Securities included in the Registration Statement to which the Claim relates. The Indemnified Party or Indemnified Person shall cooperate fully with the indemnifying party in connection with any negotiation or defense of
any such action or Claim by the indemnifying party and shall furnish to the indemnifying party all information reasonably available to the Indemnified Party or Indemnified Person which relates to such action or Claim. The indemnifying party shall
keep the Indemnified Party or Indemnified Person reasonably apprised at all times as to the status of the defense or any settlement negotiations with respect thereto. No indemnifying party shall be liable for any settlement of any action, claim or
proceeding effected without its prior written consent; provided, however, that the indemnifying party shall not unreasonably withhold, delay or condition its consent. No indemnifying party shall, without the prior written consent of
the Indemnified Party or Indemnified Person, consent to entry of any judgment or enter into any settlement or other compromise which does not include as an unconditional term thereof the giving by the claimant or plaintiff to such Indemnified Party
or Indemnified Person of a release from all liability in respect to such Claim or litigation, and such settlement shall not include any admission as to fault on the part of the Indemnified Party or Indemnified Person. Following indemnification as
provided for hereunder, the indemnifying party shall be subrogated to all rights of the Indemnified Party or Indemnified Person with respect to all third parties, firms or corporations relating to the matter for which indemnification has been made.
The failure to deliver written notice to the indemnifying party within a reasonable time of the commencement of any such action shall not relieve such indemnifying party of any liability to the Indemnified Person or Indemnified Party under this
Section 6, except to the extent that the indemnifying party is prejudiced in its ability to defend such action. 
 d. The
indemnification required by this Section 6 shall be made by periodic payments of the amount thereof during the course of the investigation or defense, as and when bills are received or Indemnified Damages are incurred. 
 e. The indemnity agreements contained herein shall be in addition to (i) any cause of action or similar right of the Indemnified Party or
Indemnified Person against the indemnifying party or others, and (ii) any liabilities the indemnifying party may be subject to pursuant to the law. 
  

 17 

 7. Contribution. 
 To the extent any indemnification by an indemnifying party is prohibited or limited by law, the indemnifying party agrees, in lieu of providing such indemnification, to contribute to the amount paid or payable by such
Indemnified Party or Indemnifying Person as a result of such Claims or Indemnified Damages, in such proportion as is appropriate to reflect the relative fault of the Company, on the one hand, and the Investors, on the other hand, in connection with
the statements or omissions which resulted in such Claims or Indemnified Damages, as well as any other relevant equitable considerations; provided, however, that (i) no Person involved in the sale of Registrable Securities which
is guilty of fraudulent misrepresentation (within the meaning of Section 11(f) of the 1933 Act) in connection with such sale shall be entitled to contribution from any Person who was not guilty of fraudulent misrepresentation and
(ii) contribution by any seller of Registrable Securities shall be limited in amount of net proceeds received by such seller from the sale of such Registrable Securities subject to the Claim. The relative fault shall be determined by reference
to, among other things, whether the untrue or alleged untrue statement of a material fact or the omission or alleged omission to state a material fact relates to information supplied by the Company, on the one hand, or the Investors, on the other
hand, and the parties’ relative intent, knowledge, access to information and opportunity to correct or prevent such statement or omission. The Company and the Investors agree that it would not be just and equitable if contribution pursuant to
this Section 7 were determined by pro rata allocation (even if the Investors were treated as one entity for such purpose) or by any other method of allocation which does not take account of the equitable considerations referred to above in this
Section 7. The amount paid or payable by an Indemnified Party or Indemnified Person as a result of the Claims or Indemnified Damages referred to above in this Section 7 shall be deemed to include any legal or other expenses reasonably
incurred by such Indemnified Party in connection with investigating or defending any such action or claim. The Investors’ obligations in this Section 7 to contribute are several in proportion to their respective underwriting obligations
and not joint. 
 8. Reports Under the 1934 Act. 
 With a view to making available to the Investors the benefits of Rule 144 promulgated under the 1933 Act or any other similar rule or regulation of the SEC that may at any time permit the Investors to sell securities
of the Company to the public without registration (“Rule 144”), the Company agrees to: 
 a. make and keep public
information available, as those terms are understood and defined in Rule 144; 
 b. file with the SEC in a timely manner all reports and
other documents required of the Company under the 1933 Act and the 1934 Act so long as the Company remains subject to such requirements and the filing of such reports and other documents is required for the applicable provisions of Rule 144; and

 c. furnish to each Investor so long as such Investor owns Registrable Securities, promptly upon request, (i) a written statement by
the Company, if true, that it has complied with the reporting requirements of Rule 144, the 1933 Act and the 1934 Act, (ii) a copy 

  

 18 

 
of the most recent annual or quarterly report of the Company and such other reports and documents so filed by the Company and (iii) such other
information as may be reasonably requested to permit the Investors to sell such securities pursuant to Rule 144 without registration. 
 9.
Assignment of Registration Rights. 
 The rights under this Agreement shall be automatically assignable by the Investors to any
transferee of all or any portion of such Investor’s Registrable Securities if: (i) the Investor agrees in writing with the transferee or assignee to assign such rights and a copy of such agreement is furnished to the Company within a
reasonable time after such assignment; (ii) the Company is, within a reasonable time after such transfer or assignment, furnished with written notice of (a) the name and address of such transferee or assignee and (b) the securities
with respect to which such registration rights are being transferred or assigned; (iii) immediately following such transfer or assignment the further disposition of such securities by the transferee or assignee is restricted under the 1933 Act
or applicable state securities laws; (iv) at or before the time the Company receives the written notice contemplated by clause (ii) of this sentence the transferee or assignee agrees in writing with the Company to be bound by all of the
provisions contained herein; and (v) such transfer shall have been made in accordance with the applicable requirements of the Securities Purchase Agreement. 
 10. Amendment of Registration Rights. 
 Provisions of this Agreement may be amended and the observance
thereof may be waived (either generally or in a particular instance and either retroactively or prospectively), only with the written consent of the Company and the Required Holders. Any amendment or waiver effected in accordance with this
Section 10 shall be binding upon each Investor and the Company. No such amendment shall be effective to the extent that it applies to less than all of the Investors. No consideration shall be offered or paid to any Person to amend or consent to
a waiver or modification of any provision of any of this Agreement unless the same consideration also is offered to all of the parties to this Agreement. 
 11. Miscellaneous. 
 a. For the purposes of this Agreement, a Person is deemed to be a holder of
Registrable Securities whenever such Person owns or is deemed to own of record such Registrable Securities. If the Company receives conflicting instructions, notices or elections from two or more Persons with respect to the same Registrable
Securities, the Company shall act upon the basis of instructions, notice or election received from the such record owner of such Registrable Securities. 
 b. Any notices, consents, waivers or other communications required or permitted to be given under the terms of this Agreement must be in writing and will be deemed to have been delivered: (i) upon receipt, when
delivered personally; (ii) upon receipt, when sent by facsimile (provided confirmation of transmission is mechanically or electronically generated and kept on file by the sending party) during business hours of the receiving party, otherwise on
the next Business Day; or (iii) one (1) Business Day after deposit with a nationally recognized 

  

 19 

 
overnight delivery service, in each case properly addressed to the party to receive the same. The addresses and facsimile numbers for such communications
shall be: 
  

			
	If to the Company:
	
	 Verenium Corporation

	 55 Cambridge Parkway

	 Cambridge, Massachusetts 02142

	 Telephone:
	    	(617) 674-5300
	 Facsimile:
	    	(617) 674-5353
	 Attention:
	    	Gerald M. Haines, Esq.
		
	Copy to:	    	
	
	 Cooley Godward Kronish LLP

	 4401 Eastgate Mall

	 San Diego, CA 92121-1900

	 Telephone:
	    	(858) 550-6000
	 Facsimile:
	    	(858) 550-6420
	 Attention:
	    	Matthew T. Browne, Esq.
	
	If to Legal Counsel:
	
	 Paul, Hastings, Janofsky & Walker LLP

	 1117 S. California Avenue

	 Palo Alto, California 94304-1106

	 Telephone:
	    	(650) 320-1884
	 Facsimile:
	    	(650) 320-1984
	 Attention:
	    	Robert Claassen, Esq.

 If to a Buyer, to its address and facsimile number set forth on the Schedule of Buyers attached hereto, with
copies to such Buyer’s representatives as set forth on the Schedule of Buyers, or to such other address and/or facsimile number and/or to the attention of such other Person as the recipient party has specified by written notice given to each
other party five (5) days prior to the effectiveness of such change. Written confirmation of receipt (A) given by the recipient of such notice, consent, waiver or other communication, (B) mechanically or electronically generated by
the sender’s facsimile machine containing the time, date, recipient facsimile number and an image of the first page of such transmission or (C) provided by a courier or overnight courier service shall be rebuttable evidence of personal
service, receipt by facsimile or receipt from a nationally recognized overnight delivery service in accordance with clause (i), (ii) or (iii) above, respectively. 
 c. Failure of any party to exercise any right or remedy under this Agreement or otherwise, or delay by a party in exercising such right or remedy, shall
not operate as a waiver thereof. 
  

 20 

 d. All questions concerning the construction, validity, enforcement and interpretation of this Agreement
shall be governed by the internal laws of the State of New York, without giving effect to any choice of law or conflict of law provision or rule (whether of the State of New York or any other jurisdictions) that would cause the application of the
laws of any jurisdictions other than the State of New York. Each party hereby irrevocably submits to the exclusive jurisdiction of the state and federal courts sitting in The City of New York, Borough of Manhattan, for the adjudication of any
dispute hereunder or in connection herewith or with any transaction contemplated hereby or discussed herein, and hereby irrevocably waives, and agrees not to assert in any suit, action or proceeding, any claim that it is not personally subject to
the jurisdiction of any such court, that such suit, action or proceeding is brought in an inconvenient forum or that the venue of such suit, action or proceeding is improper. Each party hereby irrevocably waives personal service of process and
consents to process being served in any such suit, action or proceeding by mailing a copy thereof to such party at the address for such notices to it under this Agreement and agrees that such service shall constitute good and sufficient service of
process and notice thereof. Nothing contained herein shall be deemed to limit in any way any right to serve process in any manner permitted by law. EACH PARTY HEREBY IRREVOCABLY WAIVES ANY RIGHT IT MAY HAVE, AND AGREES NOT TO REQUEST, A JURY
TRIAL FOR THE ADJUDICATION OF ANY DISPUTE HEREUNDER OR IN CONNECTION HEREWITH OR ARISING OUT OF THIS AGREEMENT OR ANY TRANSACTION CONTEMPLATED HEREBY. 
 e. This Agreement, the other Transaction Documents and the instruments referenced herein and therein constitute the entire agreement among the parties hereto with respect to the subject matter hereof and thereof.
There are no restrictions, promises, warranties or undertakings, other than those set forth or referred to herein and therein. This Agreement, the other Transaction Documents and the instruments referenced herein and therein supersede all prior
agreements and understandings among the parties hereto with respect to the subject matter hereof and thereof. 
 f. If any provision of this
Agreement is prohibited by law or otherwise determined to be invalid or unenforceable by a court of competent jurisdiction, the provision that would otherwise be prohibited, invalid or unenforceable shall be deemed amended to apply to the broadest
extent that it would be valid and enforceable, and the invalidity or unenforceability of such provision shall not affect the validity of the remaining provisions of this Agreement so long as this Agreement as so modified continues to express,
without material change, the original intentions of the parties as to the subject matter hereof and the prohibited nature, invalidity or unenforceability of the provision(s) in question does not substantially impair the respective expectations or
reciprocal obligations of the parties or the practical realization of the benefits that would otherwise be conferred upon the parties. The parties will endeavor in good faith negotiations to replace the prohibited, invalid or unenforceable
provision(s) with a valid provision(s), the effect of which comes as close as possible to that of the prohibited, invalid or unenforceable provision(s). 
 g. Subject to the requirements of Section 9, this Agreement shall inure to the benefit of and be binding upon the permitted successors and assigns of each of the parties hereto. 
  

 21 

 h. The headings in this Agreement are for convenience of reference only and shall not limit or otherwise
affect the meaning hereof. 
 i. This Agreement may be executed in identical counterparts, each of which shall be deemed an original but all
of which shall constitute one and the same agreement. This Agreement, once executed by a party, may be delivered to the other party hereto by facsimile transmission of a copy of this Agreement bearing the signature of the party so delivering this
Agreement. 
 j. Each party shall do and perform, or cause to be done and performed, all such further acts and things, and shall execute and
deliver all such other agreements, certificates, instruments and documents, as any other party may reasonably request in order to carry out the intent and accomplish the purposes of this Agreement and the consummation of the transactions
contemplated hereby. 
 k. All consents and other determinations required to be made by the Investors pursuant to this Agreement shall be
made, unless otherwise specified in this Agreement, by the Required Holders. 
 l. The language used in this Agreement will be deemed to be
the language chosen by the parties to express their mutual intent and no rules of strict construction will be applied against any party. 
 m. This Agreement is intended for the benefit of the parties hereto and their respective permitted successors and assigns, and is not for the benefit of, nor may any provision hereof be enforced by, any other Person. 
 n. The obligations of each Investor hereunder are several and not joint with the obligations of any other Investor, and no provision of this Agreement
is intended to confer any obligations on any Investor vis-à-vis any other Investor. Nothing contained herein, and no action taken by any Investor pursuant hereto, shall be deemed to constitute the Investors as a partnership, an association, a
joint venture or any other kind of entity, or create a presumption that the Investors are in any way acting in concert or as a group with respect to such obligations or the transactions contemplated herein. 
 *  *  *  *  *  * 
  

 22 

 IN WITNESS WHEREOF, each Buyer and the Company have caused their respective signature page to this
Registration Rights Agreement to be duly executed as of the date first written above. 
  

			
	COMPANY:
	
	VERENIUM CORPORATION
		
	By:	 	 /s/ Carlos A. Riva

	Name:	 	Carlos A. Riva
	Title:	 	President & Chief Executive Officer

 IN WITNESS WHEREOF, each Buyer and the Company have caused their respective signature page to this
Registration Rights Agreement to be duly executed as of the date first written above. 
  

			
	BUYERS:
	
	CAPITAL VENTURES INTERNATIONAL
		
	By:	 	 Heights Capital Management, Inc.
 its authorized agent

		
	By:	 	 /s/ Martin Kobinger

	Name:	 	Martin Kobinger
	Title:	 	Investment Manager

 IN WITNESS WHEREOF, each Buyer and the Company have caused their respective signature page to this
Registration Rights Agreement to be duly executed as of the date first written above. 
  

			
	BUYERS:
	
	RHP MASTER FUND, LTD.
		
	By:	 	Rock Hill Investment Management, L.P.
	By:	 	RHP General Partner, LLC
		
		 	 /s/ Keith Marlowe

	By:	 	Keith Marlowe
	Its:	 	Director

 IN WITNESS WHEREOF, each Buyer and the Company have caused their respective signature page to this
Registration Rights Agreement to be duly executed as of the date first written above. 
  

			
	BUYERS:
	
	 CONTEXT ADVANTAGE MASTER
 FUND
LP

		
	By:	 	 /s/ William D. Fertig

	Name:	 	William D. Fertig
	Title:	 	 Managing Member
 Context Capital Management,
LLC
 General Partner

 IN WITNESS WHEREOF, each Buyer and the Company have caused their respective signature page to this
Registration Rights Agreement to be duly executed as of the date first written above. 
  

			
	BUYERS:
	
	D. E. SHAW VALENCE PORTFOLIOS, L.L.C.
	
	By: D. E. Shaw & Co., L.P., as managing member
		
	By:	 	 /s/ Joe illegible

	Name:	 	Joe illegible
	Title:	 	Authorized signatory

 IN WITNESS WHEREOF, each Buyer and the Company have caused their respective signature page to this
Registration Rights Agreement to be duly executed as of the date first written above. 
  

			
	 BUYERS:

	
	 LINDEN CAPITAL L.P.

		
	 By:
	 	 /s/ Craig Jarvis

	 Name:
	 	Craig Jarvis
	 Title:
	 	Authorized signatory

 IN WITNESS WHEREOF, each Buyer and the Company have caused their respective signature page to this
Registration Rights Agreement to be duly executed as of the date first written above. 
  

			
	 BUYERS:

	
	 HIGHBRIDGE INTERNATIONAL LLC

		
	By:	 	 Highbridge Capital Management, LLC,
 Its Trading
Manager

		
	By:	 	 /s/ Mark J. Vanacore

	Name:	 	Mark J. Vanacore
	Title:	 	

 IN WITNESS WHEREOF, each Buyer and the Company have caused their respective signature page to this
Registration Rights Agreement to be duly executed as of the date first written above. 
  

			
	BUYERS:
	
	 HIGHBRIDGE CONVERTIBLE ARBITRAGE
 MASTER FUND, L.P.

		
	By:	 	 Highbridge Capital Management, LLC
 Its Trading
Manager

		
	By:	 	 /s/ Mark J. Vanacore

	Name:	 	Mark J. Vanacore
	Title:	 	Managing Director

 IN WITNESS WHEREOF, each Buyer and the Company have caused their respective signature page to this
Registration Rights Agreement to be duly executed as of the date first written above. 
  

			
	BUYERS:
	
	 INTERLACHEN CONVERTIBLE
 INVESTMENTS LIMITED

		
	By:	 	 Interlachen Capital Group LP
 Authorized signatory

		
	By:	 	 /s/ Gregg T. Colburn

	Name:	 	Gregg T. Colburn
	Title:	 	Authorized signatory

 IN WITNESS WHEREOF, each Buyer and the Company have caused their respective signature page to this
Registration Rights Agreement to be duly executed as of the date first written above. 
  

			
	BUYERS:
	
	PORTSIDE GROWTH AND OPPORTUNITY FUND
		
	By:	 	 /s/ Owen Littman

	Name:	 	Owen Littman
	Title:	 	Authorized signatory

 IN WITNESS WHEREOF, each Buyer and the Company have caused their respective signature page to this
Registration Rights Agreement to be duly executed as of the date first written above. 
  

			
	BUYERS:
	
	MIDSUMMER INVESTMENT, LTD.
		
	By:	 	 /s/ Michael Amsalem

	Name:	 	Michael Amsalem
	Title:	 	Director

 SCHEDULE OF BUYERS 
  

					
	 Buyer
	  	 Buyer’s Address and Facsimile Number
	  	 Buyer’s Representative’s Address and
Facsimile Number

	Capital Ventures International	  	 c/o Heights Capital Management, Inc.
 101 California
Street, Suite 3250
 San Francisco, CA 94111
 Attention: Martin
Kobinger
 Facsimile: (415) 403-6525
 Telephone: (415) 403-6500

 Residence: Cayman Islands
	  	 Paul, Hastings, Janofsky & Walker LLP
 1117 S.
California Avenue
 Palo Alto, California 94034-1106
 Attention:
Robert Claassen, Esq.
 Facsimile: (650) 320-1984
 Telephone:
(650) 320-1884

			
	Linden Capital L.P.	  	 590 Madison Avenue, 15th Floor
 New York, NY
10022
 Facsimile: (646) 840-3625
	  	
			
	RHP Master Fund, Ltd.	  	 c/o Rock Hill Investment Management, L.P.
 Three Bala
Plaza – East, Suite 585
 Bala Cynwyd, PA 19004
 Facsimile:
(610) 949-9600
 Telephone: (610) 949-9700
	  	
			
	Context Advantage Master Fund L.P.	  	 4365 Executive Drive, Suite 850
 San Diego, CA
92121
 Facsimile: (858) 481-3667
	  	
			
	D. E. Shaw Valence Portfolios, L.L.C.	  	 120 W 45th Street
 New York, NY 10036
 Facsimile: (212) 845-1635
	  	
			
	Highbridge International LLC	  	 c/o Highbridge Capital Management, LLC
 9 West 57th
Street, 27th Floor
 New York, NY 10019
 Attention: Mark Vanacore

                  Ari J. Storch/Adam J. Chill
 Facsimile: (212) 751-0755
	  	
			
	Highbridge Convertible Arbitrage Master Fund, L.P.	  	 c/o Highbridge Capital Management, LLC
 9 West 57th
Street, 27th Floor
 New York, NY 10019
 Attention: Mark Vanacore

                  Ari J. Storch/Adam J. Chill
 Facsimile: (212) 751-0755
	  	
			
	Interlachen Convertible Investments Limited	  	 c/o Goldman Sachs & Co
 One New York Plaza

New York, NY 10004
 Attention: Steve Grandstrand
 Facsimile: (212) 357-0413
 Telephone: (212) 357-7171
	  	
			
	 Portside Growth and Opportunity Fund
	  	 c/o Ramius Capital Group
 666 Third Avenue,
26th Floor
 New York, NY 10017
 Attn: Jeff Smith
 Tel: 212-201-4841
 Fax: 212-201-4802
	  	
			
	Midsummer Investment, Ltd.	  	 295 Madison Avenue, 38th Floor
 New York, NY
10017
 Attn: Josh Thomas
 Tel: 212-624-5030
 Fax: 212-624-5040
	  	 Michael Nertney, Esq.
 Feldman Weinstein & Smith LLP

 420 Lexington Avenue
 New York, NY 10170
 Facsimile: (212) 997-4242
 Telephone: (212) 869-7000

 EXHIBIT A 
 FORM OF NOTICE OF EFFECTIVENESS 
 OF REGISTRATION STATEMENT 
 American Stock Transfer & Trust Company 
 6201 15th Avenue

 Brooklyn, NY 11219 
 Attention: Ms. Donna Ansbro, Account
Administrator 
 Re: Verenium Corporation 
 Ladies and Gentlemen: 
 I am counsel to Verenium, a Delaware corporation, (the “Company,” “we,” or
“us”), and have represented the Company in connection with that certain Securities Purchase Agreement (the “Securities Purchase Agreement”) entered into by and among the Company and the buyers named therein
(collectively, the “Holders”) pursuant to which the Company sold to the Holders senior convertible notes (the “Notes”) convertible into the Company’s common stock, $0.001 par value per share
(the “Common Stock”) and warrants to acquire shares of Common Stock (as exercised, collectively, the “Warrant Shares”). Pursuant to the Securities Purchase Agreement, the Company also has entered into a
Registration Rights Agreement with the Holders (the “Registration Rights Agreement”) pursuant to which the Company agreed, among other things, to register the Registrable Securities (as defined in the Registration Rights Agreement),
including the shares of Common Stock issuable upon conversion of the Notes (the “Conversion Shares”), the Warrant Shares and the shares of Common Stock issuable, subject to certain conditions, in payment of interest on the Notes
(the “Interest Shares”), under the Securities Act of 1933, as amended (the “1933 Act”). In connection with the Company’s obligations under the Registration Rights Agreement, on
            , 200    , the Company filed a Registration Statement on Form S-3 (File
No. 333-            ) (the “Registration Statement”) with the Securities and Exchange Commission (the “SEC”) relating to the Registrable
Securities which names each of the Holders as a selling stockholder thereunder (the “Selling Shareholders”). 
 In
connection with the foregoing, we advise you that a member of the SEC’s staff has advised us by telephone that the SEC has entered an order declaring the Registration Statement effective under the 1933 Act at [TIME OF
EFFECTIVENESS] on [DATE OF EFFECTIVENESS] and we have no knowledge, after telephonic inquiry of a member of the SEC’s staff, that any stop order suspending its effectiveness has been issued or that any proceedings for that
purpose are pending before, or threatened by, the SEC. Based on the foregoing, the Registrable Securities are available for resale under the 1933 Act pursuant to the Registration Statement. 
  

 A-1 

 Each Selling Stockholder has agreed (i) pursuant to the Securities Purchase Agreement, that the
Conversion Shares, Warrant Shares and Interest Shares may not be offered for sale, sold, assigned or transferred except in compliance with the 1933 Act and (ii) pursuant to the Registration Rights Agreement, to comply with the prospectus
delivery requirements of the 1933 Act applicable to such Selling Stockholder in connection with sales of the Conversion Shares, Warrant Shares and Interest Shares pursuant to the Registration Statement or the applicable requirements of any exemption
from the 1933 Act. In reliance upon such representation, this letter shall serve as our standing instruction to you that the shares of Common Stock are freely transferable by the Holders pursuant to the Registration Statement subject to any stock
transfer instructions that we may issue to you from time to time. You need not require further letters from us to effect any future legend-free issuance or reissuance of shares of Common Stock to the Holders as contemplated by the Company’s
Irrevocable Transfer Agent Instructions dated February 22, 2008, provided at the time of such issuance or reissuance, the Company has not otherwise notified you that the Registration Statement is unavailable for the resale of the Registrable
Securities. 
  

			
	Very truly yours,
	
	VERENIUM CORPORATION
		
	By:	 	  

	Its:	 	 Executive Vice President and Chief
 Legal
Officer

  

			
	CC:	  	Capital Ventures International
		  	Linden Capital L.P.
		  	RHP Master Fund, Ltd.
		  	Context Advantage Master Fund L.P.
		  	D. E. Shaw Valence Portfolios, L.L.C.
		  	Highbridge International LLC
		  	Highbridge Convertible Arbitrage Master Fund, L.P.
		  	Interlachen Convertible Investments Limited
		  	Portside Growth and Opportunity Fund
		  	Midsummer Investment, Ltd.

  

 A-2 

 EXHIBIT B 
 SELLING STOCKHOLDERS 
 The shares of Common Stock being offered by the selling stockholders are
issuable upon conversion of the convertible notes and in payment of interest on the convertible notes. For additional information regarding the issuance of those convertible notes, see “Private Placement of Convertible Notes and Warrants”
above. We are registering the shares of Common Stock in order to permit the selling stockholders to offer the shares for resale from time to time. Except for the ownership of the convertible notes and the warrants issued pursuant to the Securities
Purchase Agreement, the selling stockholders have not had any material relationship with us within the past three years. 
 The table below
lists the selling stockholders and other information regarding the beneficial ownership of the shares of Common Stock by each of the selling stockholders. The second column lists the number of shares of Common Stock beneficially owned by each
selling stockholder, based on its ownership of the convertible notes and warrants, as of             , 200    , assuming conversion of all convertible
notes and exercise of the warrants held by the selling stockholders on that date, without regard to any limitations on conversions or exercise. 
 The third column lists the shares of Common Stock being offered by this prospectus by each selling stockholder. 
 In accordance
with the terms of a registration rights agreement among the Company and the selling stockholders, this prospectus generally covers the resale of at least 47,807,018 of the sum of the aggregate number of shares of Common Stock issued or issuable
(i) upon conversion of the convertible notes as of the trading day immediately preceding the date the registration statement is initially filed with the SEC, (ii) as Warrant Shares, pursuant to the terms of the Warrants as of the trading
day immediately preceding the date the registration statement is initially filed with the SEC, and (ii) as Interest Shares pursuant to the terms of the Notes as of the trading day immediately preceding the date the registration statement is
initially filed with the SEC. Because the conversion price of the convertible notes may be adjusted, the number of shares that will actually be issued may be more or less than the number of shares being offered by this prospectus. The fourth
column assumes the sale of all of the shares offered by the selling stockholders pursuant to this prospectus. 
 Under the terms of the
convertible notes and the warrants, a selling stockholder may not convert the convertible notes or the warrants to the extent such conversion would cause such selling stockholder, together with its affiliates, to beneficially own a number of shares
of Common Stock which would exceed 9.9% of our then outstanding shares of Common Stock following such conversion, excluding for purposes of such determination shares of Common Stock issuable upon conversion of the convertible notes or the warrants
which have not been converted. The number of shares in the second column does not reflect this limitation. The selling stockholders may sell all, some or none of their shares in this offering. See “Plan of Distribution.” 
  

 B-1 

							
	 Name of Selling Stockholder
	  	Number of Shares
Owned Prior to
Offering	  	Maximum Number of
Shares to be Sold
Pursuant to this
Prospectus	  	Number of Shares
Owned After
Offering
	 (1) Capital Ventures International
	  		  		  	0

  

	(1)	Heights Capital Management, Inc., the authorized agent of Capital Ventures International, has discretionary authority to vote and dispose of the shares held by Capital Ventures
International and may be deemed to be the beneficial owner of these shares. Capital Ventures International is affiliated with one or more registered broker-dealers. Capital Ventures International purchased the shares being registered hereunder in
the ordinary course of business and at the time of purchase, had no agreements or understandings, directly or indirectly, with any other person to distribute such shares. 

  

 B-2 

 EXHIBIT C 
 PLAN OF DISTRIBUTION 
 We are registering the shares of Common Stock issuable upon conversion of the
convertible notes and as interest on the convertible notes and issuable upon exercise of the warrants to permit the resale of these shares of Common Stock by the holders of the convertible notes and warrants from time to time after the date of this
prospectus. We will not receive any of the proceeds from the sale by the selling stockholders of the shares of Common Stock. We will bear all fees and expenses incident to our obligation to register the shares of Common Stock. 
 The selling stockholders may sell all or a portion of the shares of Common Stock beneficially owned by them and offered hereby from time to time directly
or through one or more underwriters, broker-dealers or agents. If the shares of Common Stock are sold through underwriters or broker-dealers, the selling stockholders will be responsible for paying any underwriting discounts or commissions or
agent’s commissions. The shares of Common Stock may be sold in one or more transactions at fixed prices, at prevailing market prices at the time of the sale, at varying prices determined at the time of sale, or at negotiated prices or any
combination of the foregoing. These sales may be effected in transactions, which may involve: 
  

	 	•	 	 crosses or block transactions or other transaction 

  

	 	•	 	 on any national securities exchange or quotation service on which the securities may be listed or quoted at the time of sale; 

  

	 	•	 	 transactions in the over-the-counter market; 

  

	 	•	 	 transactions otherwise than on these exchanges or systems or in the over-the-counter market; 

  

	 	•	 	 the writing of options, whether such options are listed on an options exchange or otherwise; 

  

	 	•	 	 ordinary brokerage transactions and transactions in which the broker-dealer solicits purchasers; 

  

	 	•	 	 block trades in which the broker-dealer will attempt to sell the shares as agent but may position and resell a portion of the block as principal to facilitate the
transaction; 

  

	 	•	 	 purchases by a broker-dealer as principal and resale by the broker-dealer for its account; 

  

	 	•	 	 an exchange distribution in accordance with the rules of the applicable exchange; 

  

	 	•	 	 privately negotiated transactions; 

  

	 	•	 	 short sales; 

  

 C-1 

	 	•	 	 sales pursuant to Rule 144; 

  

	 	•	 	 transactions where broker-dealers may agree with the selling securityholders to sell a specified number of such shares at a stipulated price per share;

  

	 	•	 	 a combination of any such methods of sale; and 

  

	 	•	 	 any other method permitted pursuant to applicable law. 

 If the selling stockholders effect such transactions by selling shares of Common Stock to or through underwriters, broker-dealers or agents, such underwriters, broker-dealers or agents may receive commissions in the
form of discounts, concessions or commissions from the selling stockholders or commissions from purchasers of the shares of Common Stock for whom they may act as agent or to whom they may sell as principal (which discounts, concessions or
commissions as to particular underwriters, broker-dealers or agents may be in excess of those customary in the types of transactions involved). In connection with sales of the shares of Common Stock or otherwise, the selling stockholders may enter
into hedging transactions with broker-dealers, which may in turn engage in short sales of the shares of Common Stock in the course of hedging in positions they assume. The selling stockholders may also sell shares of Common Stock short and deliver
shares of Common Stock covered by this prospectus to close out short positions and to return borrowed shares in connection with such short sales. The selling stockholders may also loan or pledge shares of Common Stock to broker-dealers that in turn
may sell such shares. 
 The selling stockholders may pledge or grant a security interest in some or all of the convertible notes or shares
of Common Stock owned by them and, if they default in the performance of their secured obligations, the pledgees or secured parties may offer and sell the shares of Common Stock from time to time pursuant to this prospectus or any amendment to this
prospectus under Rule 424(b)(3) or other applicable provision of the Securities Act of 1933, as amended, amending, if necessary, the list of selling stockholders to include the pledgee, transferee or other successors in interest as selling
stockholders under this prospectus. The selling stockholders also may transfer and donate the shares of Common Stock in other circumstances in which case the transferees, donees, pledgees or other successors in interest will be the selling
beneficial owners for purposes of this prospectus, subject to any requirement of the SEC that we amend this prospectus to include the name of such transferee, donee, pledge or other successor-in-interest in this prospectus. 
 The selling stockholders and any broker-dealer participating in the distribution of the shares of Common Stock may be deemed to be
“underwriters” within the meaning of the Securities Act, and any commission paid, or any discounts or concessions allowed to, any such broker-dealer may be deemed to be underwriting commissions or discounts under the Securities Act. At the
time a particular offering of the shares of Common Stock is made, a prospectus supplement, if required, will be distributed which will set forth the aggregate amount of shares of Common Stock being offered and the terms of the offering, including
the name or names of any broker-dealers or agents, any discounts, commissions and other terms constituting compensation from the selling stockholders and any discounts, commissions or concessions allowed or reallowed or paid to broker-dealers.

  

 C-2 

 Under the securities laws of some states, the shares of Common Stock may be sold in such states only
through registered or licensed brokers or dealers. In addition, in some states the shares of Common Stock may not be sold unless such shares have been registered or qualified for sale in such state or an exemption from registration or qualification
is available and is complied with. 
 There can be no assurance that any selling stockholder will sell any or all of the shares of Common
Stock registered pursuant to the registration statement, of which this prospectus forms a part. 
 The selling stockholders and any other
person participating in such distribution will be subject to applicable provisions of the 1934 Act and the rules and regulations thereunder, including, without limitation, Regulation M of the 1934 Act, which may limit the timing of purchases and
sales of any of the shares of Common Stock by the selling stockholders and any other participating person. Regulation M may also restrict the ability of any person engaged in the distribution of the shares of Common Stock to engage in market-making
activities with respect to the shares of Common Stock. All of the foregoing may affect the marketability of the shares of Common Stock and the ability of any person or entity to engage in market-making activities with respect to the shares of Common
Stock. 
 We will pay all expenses of the registration of the shares of Common Stock pursuant to the registration rights agreement, estimated
to be $[            ] in total, including, without limitation, SEC filing fees and expenses of compliance with state securities or “blue sky” laws; provided, however, that a
selling stockholder will pay all underwriting discounts and selling commissions, if any. We will indemnify the selling stockholders against liabilities, including some liabilities under the Securities Act, in accordance with the registration rights
agreements, or the selling stockholders will be entitled to contribution. We may be indemnified by the selling stockholders against civil liabilities, including liabilities under the Securities Act, that may arise from any written information
furnished to us by the selling stockholder specifically for use in this prospectus, in accordance with the related registration rights agreement, or we may be entitled to contribution. 
 Once sold under the registration statement, of which this prospectus forms a part, the shares of Common Stock will be freely tradable in the hands of
persons other than our affiliates. 
  

 C-3 

 EXHIBIT D 
 SELLING STOCKHOLDER QUESTIONNAIRE 
  

			
	To:	  	Verenium Corporation
		  	55 Cambridge Parkway
		  	Cambridge, Massachusetts 02142
		  	Attention: Gerald M. Haines, Esq.
		
	Copy to:	  	Cooley Godward Kronish LLP
		  	440 Eastgate Mall
		  	San Diego, CA 92121-1900
		  	Attention: Matthew T. Browne, Esq.

 Reference is made to the Registration Rights Agreement, dated as of February 22, 2008 (the
“Agreement”), by and between Verenium Corporation, a Delaware corporation (the “Company”), and the undersigned Buyers thereto. 
 Pursuant to Section 4(a) of the Agreement, the undersigned hereby furnishes to the Company the following information for use by the Company in connection with the preparation of the Registration Statement contemplated by
Section 4(a) of the Agreement. 
 (1) Name and Contact Information: 
  

			
	 Full legal name of record holder:
	 	  

		
	 Address of record holder:
	 	  

		
		 	  

		
	 Social Security Number or Taxpayer
	 	
	 identification number of record holder:
	 	  

		
	 Identity of beneficial owner (if
	 	
	 different than record holder):
	 	  

		
	 Name of contact person:
	 	  

		
	 Telephone number of contact person:
	 	  

		
	 Fax number of contact person:
	 	  

		
	 E-mail address of contact person:
	 	  

  

 D-1 

 (2) Beneficial Ownership of Registrable Securities: 
  

	
	 (a)    Number of Registrable Securities owned by Selling Stockholder:

	
	  

	
	 (b)    Number of Registrable Securities requested to be registered:

	
	  

 (3) Beneficial Ownership of Other Securities of the Company Owned by the Selling
Stockholder: 
  

	
	Except as set forth below in this Item (3), the undersigned is not the beneficial or registered owner of any securities of the Company other than the Registrable Securities listed above in Item
(2)(a).
	  
 Type and amount of other securities
beneficially owned by the Selling Stockholder:

	  

	  

 (4) Relationships with the Company: 
  

	
	Except as set forth below, neither the undersigned nor any of its affiliates, officers, directors or principal equity holders (10% or more) has held any position or office or has had any other
material relationship with the Company (or its predecessors or affiliates) during the past three years.
	
	 State any exceptions here:

	  

	  

 (5) Plan of Distribution: 
  

	
	Except as set forth below, the undersigned intends to distribute pursuant to the Registration Statement the Registrable Securities listed above in Item (2) in accordance with the “Plan of
Distribution” section set forth therein:
	
	 State any exceptions here:

	  

	  

  

 D-2 

 (6) Selling Stockholder Affiliations: 
  

	
	(a) Is the Selling Stockholder a registered broker-dealer?
	  

	
	(b) Is the Selling Stockholder an affiliate of a registered broker-dealer(s)? (For purposes of this response, an “affiliate” of, or person “affiliated” with, a specified
person, is a person that directly, or indirectly through one or more intermediaries, controls or is controlled by, or is under common control with, the person specified.)
	  

	
	(c) If the answer to Item (6)(b) is yes, identify the registered broker-dealer(s) and describe the nature of the affiliation(s):
	  

	
	(d) If the answer to Item (6)(b) is yes, did the Selling Stockholder acquire the Registrable Securities in the ordinary course of business (if not, please explain)?
	  

	
	(e) If the answer to Item (6)(b) is yes, did the Selling Stockholder, at the time of purchase of the Registrable Securities, have any agreements, plans or understandings, directly or
indirectly, with any person to distribute the Registrable Securities (if yes, please explain)?
	  

 (7) Voting or Investment Control over the Registrable Securities: 
  

	
	If the Selling Stockholder is not a natural person, please identify any natural person or persons who have voting or investment control over the Registrable Securities listed in Item (2) above:

	  

 The undersigned hereby further acknowledges that pursuant to Section 6(b) of the
Agreement, the undersigned shall indemnify the Company and each of its directors and officers against, and hold the Company and each of its directors and officers harmless from, any losses, claims, damages, expenses or liabilities (including
reasonable attorneys fees) to which the Company or its directors and officers may become subject by reason of any statement or omission in the Registration Statement made in reliance upon, or in conformity with, a written statement by the
undersigned, including the information furnished in this Questionnaire by the undersigned. 
  

 D-3 

 By signing below, the undersigned consents to the disclosure of the information contained herein in its
answers to Items (1) through (7) above and the inclusion of such information in the Registration Statement, any amendments thereto and the related prospectus. The undersigned understands that such information will be relied upon by the
Company in connection with the preparation or amendment of the Registration Statement and the related prospectus. 
 The undersigned has
reviewed the answers to the above questions and affirms that the same are true, complete and accurate. THE UNDERSIGNED AGREES TO NOTIFY THE COMPANY IMMEDIATELY OF ANY CHANGES IN THE FOREGOING INFORMATION. 
  

			
	 Dated:                     ,
20    
	 	  

		 	 Signature of Record Holder
 (Please sign your name in
exactly the
 same manner as the certificate(s) for the shares being
 registered)

  

 D-4Form of Officers' Certificate setting forth the terms of the Notes

 Exhibit 4.09 
 ORACLE CORPORATION 
 Officers’ Certificate 
 Reference is made to the Indenture dated as of January 13, 2006 (the “Base Indenture”) by and among Oracle Corporation (the
“Issuer,” formerly known as Ozark Holding Inc.), Oracle Systems Corporation (formerly known as Oracle Corporation) and Citibank, N.A., as amended by the First Supplemental Indenture dated as of May 9, 2007 (together with the
Base Indenture, the “Indenture”) by and among the Issuer, Citibank, N.A. and The Bank of New York Trust Company, N.A. On June 29, 2007, Citibank, N.A. resigned as the original trustee under the indenture and the Issuer
appointed The Bank of New York Trust Company, N.A. as successor trustee (the “Trustee”). The Trustee is the trustee for any and all securities issued under the Indenture. Pursuant to Section 2.01 and Section 2.03 of the
Indenture the undersigned officers do hereby certify, in connection with the issuance of (i) $1,250,000,000 aggregate principal amount of 4.950% Notes due 2013 (“2013 Notes”), (ii) $2,500,000,000 aggregate principal amount
of 5.750% Notes due 2018 (“2018 Notes”) and (iii) $1,250,000,000 aggregate principal amount of 6.500% Notes due 2038 (“2038 Notes,” and, together with the 2013 Notes and the 2018 Notes, the
“Notes”), that the terms of the Notes are as follows: 
 Capitalized terms used but not otherwise defined herein shall have
the meanings specified in the Indenture. 
 2013 Notes 
  

			
	Title:	  	4.950% Notes due 2013
		
	Issuer:	  	Oracle Corporation
		
	 Trustee, Registrar, Transfer Agent, Authenticating Agent,
 and Paying Agent:
	  	The Bank of New York Trust Company, N.A.
		
	Aggregate Principal Amount at Maturity:	  	$1,250,000,000
		
	Principal Payment Date:	  	April 15, 2013
		
	Interest:	  	4.950% per annum

			
	Date from which Interest will Accrue:	  	April 9, 2008
		
	Interest Payment Dates:	  	April 15 and October 15, commencing on October 15, 2008
		
	Redemption:	  	 The Issuer may at its option redeem the 2013 Notes in whole or in part, at any time or from time to time prior to their maturity, on at least 30
days, but not more than 60 days, prior notice mailed to the registered address of each holder of the 2013 Notes, at a redemption price, calculated by the Issuer, equal to the greater of:
  
 (i) 100% of the principal amount of the 2013 Notes being redeemed; and
  
 (ii) the sum of the present values of the remaining scheduled payments of principal and interest
thereon (exclusive of interest accrued as of the date of redemption) discounted to the redemption date on a semiannual basis (assuming a 360-day year consisting of twelve 30-day months) of the 2013 Notes being redeemed at the Treasury Rate (as
defined in the 2013 Notes) plus 35 basis points,
  
 plus, in each case, accrued interest
thereon to the date of redemption.

		
	Conversion:	  	None
		
	Sinking Fund:	  	None
		
	Denominations:	  	$2,000 and multiples of $1,000 thereafter
		
	Miscellaneous:	  	The terms of the 2013 Notes shall include such other terms as are set forth in the form of 2013 Notes attached hereto as Exhibit A and in the Indenture.
		
	2018 Notes	  	
		
	Title:	  	5.750% Notes due 2018
		
	Issuer:	  	Oracle Corporation

			
	Trustee, Registrar, Transfer Agent, Authenticating Agent, and Paying Agent:	  	The Bank of New York Trust Company, N.A.
		
	Aggregate Principal Amount at Maturity:	  	$2,500,000,000
		
	Principal Payment Date:	  	April 15, 2018
		
	Interest:	  	5.750% per annum
		
	Date from which Interest will Accrue:	  	April 9, 2008
		
	Interest Payment Dates:	  	April 15 and October 15, commencing on October 15, 2008
		
	Redemption:	  	 The Issuer may at its option redeem the 2018 Notes in whole or in part, at any time or from time to time prior to their maturity, on at least 30
days, but not more than 60 days, prior notice mailed to the registered address of each holder of the 2018 Notes, at a redemption price, calculated by the Issuer, equal to the greater of:
  
 (i) 100% of the principal amount of the 2018 Notes being redeemed; and
  
 (ii) the sum of the present values of the remaining scheduled payments of principal and interest
thereon (exclusive of interest accrued as of the date of redemption) discounted to the redemption date on a semiannual basis (assuming a 360-day year consisting of twelve 30-day months) of the 2018 Notes being redeemed at the Treasury Rate (as
defined in the 2018 Notes) plus 35 basis points,
  
 plus, in each case, accrued interest
thereon to the date of redemption.

		
	Conversion:	  	None
		
	Sinking Fund:	  	None
		
	Denominations:	  	$2,000 and multiples of $1,000 thereafter
		
	Miscellaneous:	  	The terms of the 2018 Notes shall include such other terms as are set forth in the form of 2018 Notes attached hereto as Exhibit B and in the Indenture.

			
	2038 Notes	  	
		
	Title:	  	6.500% Notes due 2038
		
	Issuer:	  	Oracle Corporation
		
	 Trustee, Registrar, Transfer Agent, Authenticating Agent,
 and Paying Agent:
	  	The Bank of New York Trust Company, N.A.
		
	Aggregate Principal Amount at Maturity:	  	$1,250,000,000
		
	Principal Payment Date:	  	April 15, 2038
		
	Interest:	  	6.500% per annum
		
	Date from which Interest will Accrue:	  	April 9, 2008
		
	Interest Payment Dates:	  	April 15 and October 15, commencing on October 15, 2008

			
	Redemption:	  	 The Issuer may at its option redeem the 2038 Notes in whole or in part, at any time or from time to time prior to their maturity, on at least 30
days, but not more than 60 days, prior notice mailed to the registered address of each holder of the 2038 Notes, at a redemption price, calculated by the Issuer, equal to the greater of:
  
 (i) 100% of the principal amount of the 2038 Notes being redeemed; and
  
 (ii) the sum of the present values of the remaining scheduled payments of principal and interest
thereon (exclusive of interest accrued as of the date of redemption) discounted to the redemption date on a semiannual basis (assuming a 360-day year consisting of twelve 30-day months) of the 2038 Notes being redeemed at the Treasury Rate (as
defined in the 2038 Notes) plus 35 basis points,
  
 plus, in each case, accrued interest
thereon to the date of redemption.

		
	Conversion:	  	None
		
	Sinking Fund:	  	None
		
	Denominations:	  	$2,000 and multiples of $1,000 thereafter
		
	Miscellaneous:	  	The terms of the 2038 Notes shall include such other terms as are set forth in the form of 2038 Notes attached hereto as Exhibit C and in the Indenture.

 Subject to the representations, warranties and covenants described in the Indenture, as amended or
supplemented from time to time, the Issuer shall be entitled, subject to authorization by the Board of Directors of the Issuer and an Officers’ Certificate, to issue additional notes from time to time under each series of notes issued hereby.
Any such additional notes of a series shall have identical terms as the 2013 Notes, the 2018 Notes or the 2038 Notes, as the case may be, issued on the issue date, other than with respect to the date of issuance and the issue price (together the
“Additional Notes”). Any Additional Notes will be issued in accordance with Section 2.03 of the Indenture. 

 Each such officer has read and understands the provisions of the Indenture and the definitions relating
thereto. The statements made in this Officers’ Certificate are based upon the examination of the provisions of the Indenture and upon the relevant books and records of the Issuer. In such officers’ opinion, they have made such examination
or investigation as is necessary to enable such officers to express an informed opinion as to whether or not the covenants and conditions of such Indenture relating to the issuance and authentication of the Notes have been complied with. In such
officers’ opinion, such covenants and conditions have been complied with. 

 IN WITNESS WHEREOF, the undersigned officers of the Issuer have duly executed this certificate as of
April 9, 2008. 
  

			
	ORACLE CORPORATION
		
	By:	 	 
		 	 Name: Safra A. Catz
 Title: President and Chief
Financial Officer

		
	By:	 	 
		 	 Name: Eric R. Ball
 Title: Vice President and
Treasurer

 EXHIBIT A 
 [FORM OF NOTES DUE 2013] 
 UNLESS THIS NOTE IS PRESENTED BY AN AUTHORIZED REPRESENTATIVE OF THE DEPOSITORY
TRUST COMPANY, A NEW YORK CORPORATION (“DTC”), TO THE ISSUER OR ITS AGENT FOR REGISTRATION OF TRANSFER, EXCHANGE OR PAYMENT, AND ANY NOTE ISSUED IS REGISTERED IN THE NAME OF CEDE & CO. OR IN SUCH OTHER NAME AS IS REQUESTED
BY AN AUTHORIZED REPRESENTATIVE OF DTC (AND ANY PAYMENT IS MADE TO CEDE & CO. OR TO SUCH OTHER ENTITY AS IS REQUESTED BY AN AUTHORIZED REPRESENTATIVE OF DTC), ANY TRANSFER, PLEDGE OR OTHER USE HEREOF FOR VALUE OR OTHERWISE BY OR TO ANY
PERSON IS WRONGFUL INASMUCH AS THE REGISTERED OWNER HEREOF, CEDE & CO., HAS A BENEFICIAL INTEREST HEREIN. 
 TRANSFERS OF THIS NOTE
ARE LIMITED TO TRANSFERS IN WHOLE, BUT NOT IN PART, TO NOMINEES OF DTC OR TO A SUCCESSOR THEREOF OR SUCH SUCCESSOR’S NOMINEE AND TRANSFERS OF PORTIONS OF THIS GLOBAL NOTE ARE LIMITED TO TRANSFERS MADE IN ACCORDANCE WITH THE TRANSFER PROVISIONS
OF THE INDENTURE. 
 IN CONNECTION WITH ANY TRANSFER, THE HOLDER WILL DELIVER TO THE REGISTRAR AND TRANSFER AGENT SUCH CERTIFICATES AND OTHER
INFORMATION AS SUCH TRANSFER AGENT MAY REASONABLY REQUIRE TO CONFIRM THAT THE TRANSFER COMPLIES WITH THE FOREGOING RESTRICTIONS. 

 ORACLE CORPORATION 
 4.950% Notes due 2013 
  

			
	No.	  	CUSIP No.: 68389X AD7
		  	ISIN No.: US68389XAD75

 $[—] 
 ORACLE CORPORATION, a Delaware corporation (the “Issuer”), for value received promises to pay to CEDE & CO. or registered
assigns the principal sum of                      DOLLARS on April 15, 2013. 
 Interest Payment Dates: April 15 and October 15 (each, an “Interest Payment Date”), commencing on October 15, 2008.

 Interest Record Dates: April 1 and October 1 (each, an “Interest Record Date”). 
 Reference is made to the further provisions of this Note contained herein, which will for all purposes have the same effect as if set forth at this
place. 

 IN WITNESS WHEREOF, the Issuer has caused this Note to be signed manually or by facsimile by its duly
authorized officers. 
  

			
	ORACLE CORPORATION
		
	By:	 	 
		 	 Name: Safra A. Catz
 Title: President and Chief
Financial Officer

		
	By:	 	 
		 	 Name: Eric R. Ball
 Title: Vice President and
Treasurer

 This is one of the Notes of the series designated herein and referred to in the within-mentioned
Indenture. 
 Dated: April 9, 2008 
  

			
	 The Bank of New York Trust Company, N.A.,
     as Trustee

		
	By:	 	 
		 	Authorized Signatory

 (REVERSE OF NOTE) 
 ORACLE CORPORATION 
 4.950% Notes due 2013 
  

	 	1.	Interest. 

 Oracle Corporation (the
“Issuer”) promises to pay interest on the principal amount of this Note at the rate per annum described above. Cash interest on the Notes will accrue from the most recent date to which interest has been paid; or, if no interest has
been paid, from April 9, 2008. Interest on this Note will be paid to but excluding the relevant Interest Payment Date. The Issuer will pay interest semi-annually in arrears on each Interest Payment Date, commencing October 15, 2008.
Interest will be computed on the basis of a 360-day year consisting of twelve 30-day months in a manner consistent with Rule 11620(b) of the NASD Uniform Practice Code. 
 The Issuer shall pay interest on overdue principal from time to time on demand at the rate borne by the Notes and on overdue installments of interest (without regard to any applicable grace periods) to the extent
lawful. 
  

	 	2.	Paying Agent. 

 Initially, The Bank of New York Trust
Company, N.A. (the “Trustee”) will act as paying agent. The Issuer may change any paying agent without notice to the Holders. 
  

	 	3.	Indenture; Defined Terms. 

 This Note is one of the 4.950%
Notes due 2013 (the “Notes”) issued under an indenture dated as of January 13, 2006 (the “Base Indenture”) by and among the Issuer (formerly known as Ozark Holding Inc.), Oracle Systems Corporation (formerly
known as Oracle Corporation) and Citibank, N.A., as amended by a supplemental indenture dated as of May 9, 2007 (together with the Base Indenture, the “Indenture”) by and among the Issuer, Citibank, N.A. and the Trustee, and
established pursuant to an Officers’ Certificate dated April 9, 2008, issued pursuant to Section 2.01 and Section 2.03 thereof (together, the “Indenture”). This Note is a “Security” and the Notes are
“Securities” under the Indenture. 

 For purposes of this Note, unless otherwise defined herein, capitalized terms herein are used as defined
in the Indenture. The terms of the Notes include those stated in the Indenture and those made part of the Indenture by reference to the Trust Indenture Act of 1939 (15 U.S.C. Sections 77aaa-77bbbb) (the “TIA”) as in effect on the
date on which the Indenture was qualified under the TIA. Notwithstanding anything to the contrary herein, the Notes are subject to all such terms, and holders of Notes are referred to the Indenture and the TIA for a statement of them. To the extent
the terms of the Indenture and this Note are inconsistent, the terms of the Indenture shall govern. 
  

	 	4.	Denominations; Transfer; Exchange. 

 The Notes are in
registered form, without coupons, in denominations of $2,000 and multiples of $1,000 thereafter. A Holder shall register the transfer or exchange of Notes in accordance with the Indenture. The Issuer may require a Holder, among other things, to
furnish appropriate endorsements and transfer documents and to pay certain transfer taxes or similar governmental charges payable in connection therewith as permitted by the Indenture. The Issuer need not issue, authenticate, register the transfer
of or exchange any Notes or portions thereof for a period of fifteen (15) days before the mailing of a notice of redemption, nor need the Issuer register the transfer or exchange of any Note selected for redemption in whole or in part.

  

	 	5.	Amendment; Supplement; Waiver. 

 Subject to certain
exceptions, the Notes and the provisions of the Indenture relating to the Notes may be amended or supplemented and any existing default or Event of Default or compliance with certain provisions may be waived with the written consent of the Holders
of at least a majority in aggregate principal amount of all series of Outstanding Securities (including the Notes) under the Indenture that are affected by such amendment, supplement or waiver (voting as a single class). Without notice to or consent
of any Holder, the parties thereto may amend or supplement the Indenture and the Notes to, among other things, cure any ambiguity, defect or inconsistency or comply with any requirements of the Commission in connection with the qualification of the
Indenture under the TIA, or make any other change that does not adversely affect the rights of any Holder of a Note. 
  

	 	6.	Redemption. 

 The Issuer may at its option redeem any of
the Notes in whole or in part at any time, each at a redemption price calculated by the Issuer equal to the greater of: 
 (i) 100% of the
principal amount of the Notes to be redeemed; and 

 (ii) the sum of the present values of the remaining scheduled payments of principal and interest thereon
(not including any portion of such payments of interest accrued as of the date of redemption), discounted to the date of redemption on a semi-annual basis (assuming a 360-day year consisting of twelve 30-day months) at the Treasury Rate (as defined
below) plus 35 basis points, 
 plus in each case accrued interest thereon to the date of redemption. 
 Notwithstanding the foregoing, installments of interest on Notes that are due and payable on interest payment dates falling on or prior to a redemption
date will be payable on the interest payment date to the registered Holders as of the close of business on the relevant record date according to the Notes and the Indenture. 
 “Comparable Treasury Issue” means the United States Treasury security selected by the Quotation Agent as having a maturity comparable to
the remaining term of the Notes to be redeemed that would be utilized, at the time of selection and in accordance with customary financial practice, in pricing new issues of corporate debt securities of comparable maturity to the remaining term of
the Notes. 
 “Comparable Treasury Price” means, with respect to any redemption date, (i) the average of four Reference
Treasury Dealer Quotations for such redemption date, after excluding the highest and lowest such Reference Treasury Dealer Quotations, or (ii) if the Quotation Agent obtains fewer than four such Reference Treasury Dealer Quotations, the average
of all such quotations, or (iii) if only one Reference Treasury Dealer Quotation is received, such quotation. 
 “Quotation
Agent” means the Reference Treasury Dealer appointed by the Issuer. 
 “Reference Treasury Dealer” means
(i) Citigroup Global Markets Inc., Credit Suisse Securities (USA) LLC or Morgan Stanley & Co. Incorporated (or their respective affiliates that are Primary Treasury Dealers) and their respective successors; provided,
however, that if any of the foregoing shall cease to be a primary U.S. Government securities dealer in New York City (a “Primary Treasury Dealer”), the Issuer will substitute therefor another Primary Treasury Dealer, and
(ii) any other Primary Treasury Dealer selected by the Issuer. 
 “Reference Treasury Dealer Quotations” means, with
respect to each Reference Treasury Dealer and any redemption date, the average, as determined by the Quotation Agent, of the bid and asked prices for the Comparable Treasury Issue (expressed in each case as a percentage of its principal amount)
quoted in writing to the Quotation Agent by such Reference Treasury Dealer at 5:00 p.m., New York City time, on the third business day preceding such redemption date. 

 “Treasury Rate” means, with respect to any redemption date, the rate per annum equal to
the semi-annual equivalent yield to maturity of the Comparable Treasury Issue, assuming a price for the Comparable Treasury Issue (expressed as a percentage of its principal amount) equal to the Comparable Treasury Price for such redemption date.

 Notice of any redemption will be mailed at least 30 days but not more than 60 days before the redemption date to each Holder of
the Notes to be redeemed. Unless the Issuer defaults in payment of the redemption price, on and after the redemption date, interest will cease to accrue on the Notes or portions thereof called for redemption. If less than all of the Notes are to be
redeemed, the Notes to be redeemed shall be selected by lot by the Depositary, in the case of Notes represented by a Global Note, or by the Trustee by a method the Trustee deems to be fair and appropriate, in the case of Notes that are not
represented by a Global Note. 
  

	 	7.	Defaults and Remedies. 

 If an Event of Default (other than
certain bankruptcy Events of Default with respect to the Issuer) under the Indenture occurs with respect to the Notes and is continuing, then the Trustee may and, at the direction of the Holders of at least 25% in principal amount of the outstanding
Notes, shall by written notice, require the Issuer to repay immediately the entire principal amount of the Outstanding Notes, together with all accrued and unpaid interest and premium, if any. If a bankruptcy Event of Default with respect to the
Issuer occurs and is continuing, then the entire principal amount of the Outstanding Notes will automatically become due immediately and payable without any declaration or other act on the part of the Trustee or any Holder. Holders of Notes may not
enforce the Indenture or the Notes except as provided in the Indenture. The Trustee is not obligated to enforce the Indenture or the Notes unless it has received indemnity as it reasonably requires. The Indenture permits, subject to certain
limitations therein provided, Holders of a majority in aggregate principal amount of the Notes then outstanding to direct the Trustee in its exercise of any trust or power. The Trustee may withhold from Holders of Notes notice of certain continuing
defaults or Events of Default if it determines that withholding notice is in their interest. 
  

	 	8.	Authentication. 

 This Note shall not be valid until the
Trustee manually signs the certificate of authentication on this Note. 
  

	 	9.	Abbreviations and Defined Terms. 

 Customary abbreviations
may be used in the name of a Holder of a Note or an assignee, such as: TEN COM (= tenants in common), TEN ENT (= tenants by the entireties), JT TEN (= joint tenants with right of survivorship and not as tenants in common), CUST (= Custodian),
and U/G/M/A (= Uniform Gifts to Minors Act). 

	 	10.	CUSIP Numbers. 

 Pursuant to a recommendation promulgated
by the Committee on Uniform Security Identification Procedures, the Issuer has caused CUSIP numbers to be printed on the Notes as a convenience to the Holders of the Notes. No representation is made as to the accuracy of such numbers as printed on
the Notes and reliance may be placed only on the other identification numbers printed hereon. 
  

	 	11.	Governing Law. 

 The laws of the State of New York shall
govern the Indenture and this Note thereof. 

 ASSIGNMENT FORM 
 To assign this Note, fill in the form below: 
 I or we assign and transfer this Note to 
  

					
		  	(Print or type assignee’s name, address and zip code)	  	
			
		  	(Insert assignee’s soc. sec. or tax I.D. No.)	  	

 and irrevocably appoint
                            agent to transfer this Note on the books of the Issuer. The agent may substitute
another to act for him. 
  

									
					
	 	  	 	  	 	  	 	  	 
					
		  		  		  		  	
					
	 Date:
	  	 	  	Your Signature:	  	 	  	
					
		  		  		  		  	
					
	 	  	 	  	 	  	 	  	 
	
	Sign exactly as your name appears on the other side of this Note.

  

					
			
	 	 		 	  
		 		 	Signature
	Signature Guarantee:	 		 	
			
	  	 		 	  
	Signature must be guaranteed	 		 	Signature

 Signatures must be guaranteed by an “eligible guarantor institution” meeting the
requirements of the Registrar, which requirements include membership or participation in the Security Transfer Agent Medallion Program (“STAMP”) or such other “signature guarantee program” as may be determined by the
Registrar in addition to, or in substitution for, STAMP, all in accordance with the United States Securities Exchange Act of 1934, as amended. 

 SCHEDULE OF EXCHANGES OF NOTES 
 The following exchanges of a part of this Global Note for Physical Notes or a part of another Global Note have been made: 
  

									
	 Date of Exchange
	  	Amount of decrease
in principal amount
of this Global Note	  	Amount of increase
in principal amount
of this Global Note	  	Principal amount of
this Global Note
following such
decrease (or
increase)	  	Signature of
authorized officer of
Trustee

 EXHIBIT B 
 [FORM OF NOTES DUE 2018] 
 UNLESS THIS NOTE IS PRESENTED BY AN AUTHORIZED REPRESENTATIVE OF THE DEPOSITORY
TRUST COMPANY, A NEW YORK CORPORATION (“DTC”), TO THE ISSUER OR ITS AGENT FOR REGISTRATION OF TRANSFER, EXCHANGE OR PAYMENT, AND ANY NOTE ISSUED IS REGISTERED IN THE NAME OF CEDE & CO. OR IN SUCH OTHER NAME AS IS REQUESTED
BY AN AUTHORIZED REPRESENTATIVE OF DTC (AND ANY PAYMENT IS MADE TO CEDE & CO. OR TO SUCH OTHER ENTITY AS IS REQUESTED BY AN AUTHORIZED REPRESENTATIVE OF DTC), ANY TRANSFER, PLEDGE OR OTHER USE HEREOF FOR VALUE OR OTHERWISE BY OR TO ANY
PERSON IS WRONGFUL INASMUCH AS THE REGISTERED OWNER HEREOF, CEDE & CO., HAS A BENEFICIAL INTEREST HEREIN. 
 TRANSFERS OF THIS NOTE
ARE LIMITED TO TRANSFERS IN WHOLE, BUT NOT IN PART, TO NOMINEES OF DTC OR TO A SUCCESSOR THEREOF OR SUCH SUCCESSOR’S NOMINEE AND TRANSFERS OF PORTIONS OF THIS GLOBAL NOTE ARE LIMITED TO TRANSFERS MADE IN ACCORDANCE WITH THE TRANSFER PROVISIONS
OF THE INDENTURE. 
 IN CONNECTION WITH ANY TRANSFER, THE HOLDER WILL DELIVER TO THE REGISTRAR AND TRANSFER AGENT SUCH CERTIFICATES AND OTHER
INFORMATION AS SUCH TRANSFER AGENT MAY REASONABLY REQUIRE TO CONFIRM THAT THE TRANSFER COMPLIES WITH THE FOREGOING RESTRICTIONS. 

 ORACLE CORPORATION 
 5.750% Notes due 2018 
  

			
	No.	  	CUSIP No.: 68389X AC9
		  	ISIN No.: US68389XAC92

 $[—] 
 ORACLE CORPORATION, a Delaware corporation (the “Issuer”), for value received promises to pay to CEDE & CO. or registered
assigns the principal sum of                      DOLLARS on April 15, 2018. 
 Interest Payment Dates: April 15 and October 15 (each, an “Interest Payment Date”), commencing on October 15, 2008.

 Interest Record Dates: April 1 and October 1 (each, an “Interest Record Date”). 
 Reference is made to the further provisions of this Note contained herein, which will for all purposes have the same effect as if set forth at this
place. 

 IN WITNESS WHEREOF, the Issuer has caused this Note to be signed manually or by facsimile by its duly
authorized officers. 
  

			
	ORACLE CORPORATION
		
	By:	 	 
		 	 Name: Safra A. Catz
 Title: President and Chief
Financial Officer

		
	By:	 	 
		 	 Name: Eric R. Ball
 Title: Vice President and
Treasurer

 This is one of the Notes of the series designated herein and referred to in the within-mentioned
Indenture. 
 Dated: April 9, 2008 
  

			
	 The Bank of New York Trust Company, N.A.,
     as Trustee

		
	By:	 	 
		 	Authorized Signatory

 (REVERSE OF NOTE) 
 ORACLE CORPORATION 
 5.750% Notes due 2018 
  

	 	1.	Interest. 

 Oracle Corporation (the
“Issuer”) promises to pay interest on the principal amount of this Note at the rate per annum described above. Cash interest on the Notes will accrue from the most recent date to which interest has been paid or, if no interest has
been paid, from April 9, 2008. Interest on this Note will be paid to but excluding the relevant Interest Payment Date. The Issuer will pay interest semi-annually in arrears on each Interest Payment Date, commencing October 15, 2008.
Interest will be computed on the basis of a 360-day year consisting of twelve 30-day months in a manner consistent with Rule 11620(b) of the NASD Uniform Practice Code. 
 The Issuer shall pay interest on overdue principal from time to time on demand at the rate borne by the Notes and on overdue installments of interest (without regard to any applicable grace periods) to the extent
lawful. 
  

	 	2.	Paying Agent. 

 Initially, The Bank of New York Trust
Company, N.A. (the “Trustee”) will act as paying agent. The Issuer may change any paying agent without notice to the Holders. 
  

	 	3.	Indenture; Defined Terms. 

 This Note is one of the 5.750%
Notes due 2018 (the “Notes”) issued under an indenture dated as of January 13, 2006 (the “Base Indenture”) by and among the Issuer (formerly known as Ozark Holding Inc.), Oracle Systems Corporation (formerly
known as Oracle Corporation) and Citibank, N.A., as amended by a supplemental indenture dated as of May 9, 2007 (together with the Base Indenture, the “Indenture”) by and among the Issuer, Citibank, N.A. and the Trustee, and
established pursuant to an Officers’ Certificate dated April 9, 2008, issued pursuant to Section 2.01 and Section 2.03 thereof (together, the “Indenture”). This Note is a “Security” and the Notes are
“Securities” under the Indenture. 

 For purposes of this Note, unless otherwise defined herein, capitalized terms herein are used as defined
in the Indenture. The terms of the Notes include those stated in the Indenture and those made part of the Indenture by reference to the Trust Indenture Act of 1939 (15 U.S.C. Sections 77aaa-77bbbb) (the “TIA”) as in effect on the
date on which the Indenture was qualified under the TIA. Notwithstanding anything to the contrary herein, the Notes are subject to all such terms, and holders of Notes are referred to the Indenture and the TIA for a statement of them. To the extent
the terms of the Indenture and this Note are inconsistent, the terms of the Indenture shall govern. 
  

	 	4.	Denominations; Transfer; Exchange. 

 The Notes are in
registered form, without coupons, in denominations of $2,000 and multiples of $1,000 thereafter. A Holder shall register the transfer or exchange of Notes in accordance with the Indenture. The Issuer may require a Holder, among other things, to
furnish appropriate endorsements and transfer documents and to pay certain transfer taxes or similar governmental charges payable in connection therewith as permitted by the Indenture. The Issuer need not issue, authenticate, register the transfer
of or exchange any Notes or portions thereof for a period of fifteen (15) days before the mailing of a notice of redemption, nor need the Issuer register the transfer or exchange of any Note selected for redemption in whole or in part.

  

	 	5.	Amendment; Supplement; Waiver. 

 Subject to certain
exceptions, the Notes and the provisions of the Indenture relating to the Notes may be amended or supplemented and any existing default or Event of Default or compliance with certain provisions may be waived with the written consent of the Holders
of at least a majority in aggregate principal amount of all series of Outstanding Securities (including the Notes) under the Indenture that are affected by such amendment, supplement or waiver (voting as a single class). Without notice to or consent
of any Holder, the parties thereto may amend or supplement the Indenture and the Notes to, among other things, cure any ambiguity, defect or inconsistency or comply with any requirements of the Commission in connection with the qualification of the
Indenture under the TIA, or make any other change that does not adversely affect the rights of any Holder of a Note. 
  

	 	6.	Redemption. 

 The Issuer may at its option redeem any of
the Notes in whole or in part at any time, each at a redemption price calculated by the Issuer equal to the greater of: 
 (i) 100% of the
principal amount of the Notes to be redeemed; and 

 (ii) the sum of the present values of the remaining scheduled payments of principal and interest thereon
(not including any portion of such payments of interest accrued as of the date of redemption), discounted to the date of redemption on a semi-annual basis (assuming a 360-day year consisting of twelve 30-day months) at the Treasury Rate (as defined
below) plus 35 basis points, 
 plus in each case accrued interest thereon to the date of redemption. 
 Notwithstanding the foregoing, installments of interest on Notes that are due and payable on interest payment dates falling on or prior to a redemption
date will be payable on the interest payment date to the registered Holders as of the close of business on the relevant record date according to the Notes and the Indenture. 
 “Comparable Treasury Issue” means the United States Treasury security selected by the Quotation Agent as having a maturity comparable to
the remaining term of the Notes to be redeemed that would be utilized, at the time of selection and in accordance with customary financial practice, in pricing new issues of corporate debt securities of comparable maturity to the remaining term of
the Notes. 
 “Comparable Treasury Price” means, with respect to any redemption date, (i) the average of four Reference
Treasury Dealer Quotations for such redemption date, after excluding the highest and lowest such Reference Treasury Dealer Quotations, or (ii) if the Quotation Agent obtains fewer than four such Reference Treasury Dealer Quotations, the average
of all such quotations, or (iii) if only one Reference Treasury Dealer Quotation is received, such quotation. 
 “Quotation
Agent” means the Reference Treasury Dealer appointed by the Issuer. 
 “Reference Treasury Dealer” means
(i) Citigroup Global Markets Inc., Credit Suisse Securities (USA) LLC or Morgan Stanley & Co. Incorporated (or their respective affiliates that are Primary Treasury Dealers) and their respective successors; provided,
however, that if any of the foregoing shall cease to be a primary U.S. Government securities dealer in New York City (a “Primary Treasury Dealer”), the Issuer will substitute therefor another Primary Treasury Dealer, and
(ii) any other Primary Treasury Dealer selected by the Issuer. 
 “Reference Treasury Dealer Quotations” means, with
respect to each Reference Treasury Dealer and any redemption date, the average, as determined by the Quotation Agent, of the bid and asked prices for the Comparable Treasury Issue (expressed in each case as a percentage of its principal amount)
quoted in writing to the Quotation Agent by such Reference Treasury Dealer at 5:00 p.m., New York City time, on the third business day preceding such redemption date. 

 “Treasury Rate” means, with respect to any redemption date, the rate per annum equal to
the semi-annual equivalent yield to maturity of the Comparable Treasury Issue, assuming a price for the Comparable Treasury Issue (expressed as a percentage of its principal amount) equal to the Comparable Treasury Price for such redemption date.

 Notice of any redemption will be mailed at least 30 days but not more than 60 days before the redemption date to each Holder of
the Notes to be redeemed. Unless the Issuer defaults in payment of the redemption price, on and after the redemption date, interest will cease to accrue on the Notes or portions thereof called for redemption. If less than all of the Notes are to be
redeemed, the Notes to be redeemed shall be selected by lot by the Depositary, in the case of Notes represented by a Global Note, or by the Trustee by a method the Trustee deems to be fair and appropriate, in the case of Notes that are not
represented by a Global Note. 
  

	 	7.	Defaults and Remedies. 

 If an Event of Default (other than
certain bankruptcy Events of Default with respect to the Issuer) under the Indenture occurs with respect to the Notes and is continuing, then the Trustee may and, at the direction of the Holders of at least 25% in principal amount of the outstanding
Notes, shall by written notice, require the Issuer to repay immediately the entire principal amount of the Outstanding Notes, together with all accrued and unpaid interest and premium, if any. If a bankruptcy Event of Default with respect to the
Issuer occurs and is continuing, then the entire principal amount of the Outstanding Notes will automatically become due immediately and payable without any declaration or other act on the part of the Trustee or any Holder. Holders of Notes may not
enforce the Indenture or the Notes except as provided in the Indenture. The Trustee is not obligated to enforce the Indenture or the Notes unless it has received indemnity as it reasonably requires. The Indenture permits, subject to certain
limitations therein provided, Holders of a majority in aggregate principal amount of the Notes then outstanding to direct the Trustee in its exercise of any trust or power. The Trustee may withhold from Holders of Notes notice of certain continuing
defaults or Events of Default if it determines that withholding notice is in their interest. 
  

	 	8.	Authentication. 

 This Note shall not be valid until the
Trustee manually signs the certificate of authentication on this Note. 
  

	 	9.	Abbreviations and Defined Terms. 

 Customary abbreviations
may be used in the name of a Holder of a Note or an assignee, such as: TEN COM (= tenants in common), TEN ENT (= tenants by the entireties), JT TEN (= joint tenants with right of survivorship and not as tenants in common), CUST (= Custodian),
and U/G/M/A (= Uniform Gifts to Minors Act). 

	 	10.	CUSIP Numbers. 

 Pursuant to a recommendation promulgated
by the Committee on Uniform Security Identification Procedures, the Issuer has caused CUSIP numbers to be printed on the Notes as a convenience to the Holders of the Notes. No representation is made as to the accuracy of such numbers as printed on
the Notes and reliance may be placed only on the other identification numbers printed hereon. 
  

	 	11.	Governing Law. 

 The laws of the State of New York shall
govern the Indenture and this Note thereof. 

 ASSIGNMENT FORM 
 To assign this Note, fill in the form below: 
 I or we assign and transfer this Note to 
  

					
		  	(Print or type assignee’s name, address and zip code)	  	
			
		  	(Insert assignee’s soc. sec. or tax I.D. No.)	  	

 and irrevocably appoint
                            agent to transfer this Note on the books of the Issuer. The agent may substitute
another to act for him. 
  

									
					
	 	  	 	  	 	  	 	  	 
					
		  		  		  		  	
					
	 Date:
	  	 	  	Your Signature:	  	 	  	
					
		  		  		  		  	
					
	 	  	 	  	 	  	 	  	 
	
	 Sign exactly as your name appears on the other side of this Note.
  

					
			
	 	 		 	  
		 		 	Signature
	Signature Guarantee:	 		 	
			
	  	 		 	  
	Signature must be guaranteed	 		 	Signature

 Signatures must be guaranteed by an “eligible guarantor institution” meeting the
requirements of the Registrar, which requirements include membership or participation in the Security Transfer Agent Medallion Program (“STAMP”) or such other “signature guarantee program” as may be determined by the
Registrar in addition to, or in substitution for, STAMP, all in accordance with the United States Securities Exchange Act of 1934, as amended. 

 SCHEDULE OF EXCHANGES OF NOTES 
 The following exchanges of a part of this Global Note for Physical Notes or a part of another Global Note have been made: 
  

									
	 Date of Exchange
	  	Amount of decrease
in principal amount
of this Global Note	  	Amount of increase
in principal amount
of this Global Note	  	Principal amount of
this Global Note
following
such
decrease (or
increase)	  	Signature of
authorized officer of
Trustee

 EXHIBIT C 
 [FORM OF NOTES DUE 2038] 
 UNLESS THIS NOTE IS PRESENTED BY AN AUTHORIZED REPRESENTATIVE OF THE DEPOSITORY
TRUST COMPANY, A NEW YORK CORPORATION (“DTC”), TO THE ISSUER OR ITS AGENT FOR REGISTRATION OF TRANSFER, EXCHANGE OR PAYMENT, AND ANY NOTE ISSUED IS REGISTERED IN THE NAME OF CEDE & CO. OR IN SUCH OTHER NAME AS IS REQUESTED
BY AN AUTHORIZED REPRESENTATIVE OF DTC (AND ANY PAYMENT IS MADE TO CEDE & CO. OR TO SUCH OTHER ENTITY AS IS REQUESTED BY AN AUTHORIZED REPRESENTATIVE OF DTC), ANY TRANSFER, PLEDGE OR OTHER USE HEREOF FOR VALUE OR OTHERWISE BY OR TO ANY
PERSON IS WRONGFUL INASMUCH AS THE REGISTERED OWNER HEREOF, CEDE & CO., HAS A BENEFICIAL INTEREST HEREIN. 
 TRANSFERS OF THIS NOTE
ARE LIMITED TO TRANSFERS IN WHOLE, BUT NOT IN PART, TO NOMINEES OF DTC OR TO A SUCCESSOR THEREOF OR SUCH SUCCESSOR’S NOMINEE AND TRANSFERS OF PORTIONS OF THIS GLOBAL NOTE ARE LIMITED TO TRANSFERS MADE IN ACCORDANCE WITH THE TRANSFER PROVISIONS
OF THE INDENTURE. 
 IN CONNECTION WITH ANY TRANSFER, THE HOLDER WILL DELIVER TO THE REGISTRAR AND TRANSFER AGENT SUCH CERTIFICATES AND OTHER
INFORMATION AS SUCH TRANSFER AGENT MAY REASONABLY REQUIRE TO CONFIRM THAT THE TRANSFER COMPLIES WITH THE FOREGOING RESTRICTIONS. 

 ORACLE CORPORATION 
 6.500% Notes due 2038 
  

			
	No.	  	CUSIP No.: 68389X AE5
		  	ISIN No.: US68389XAE58

 $[—] 
 ORACLE CORPORATION, a Delaware corporation (the “Issuer”), for value received promises to pay to CEDE & CO. or registered
assigns the principal sum of                      DOLLARS on April 15, 2038. 
 Interest Payment Dates: April 15 and October 15 (each, an “Interest Payment Date”), commencing on October 15, 2008.

 Interest Record Dates: April 1 and October 1 (each, an “Interest Record Date”). 
 Reference is made to the further provisions of this Note contained herein, which will for all purposes have the same effect as if set forth at this
place. 

 IN WITNESS WHEREOF, the Issuer has caused this Note to be signed manually or by facsimile by its duly
authorized officers. 
  

			
	ORACLE CORPORATION
		
	By:	 	 
		 	 Name: Safra A. Catz
 Title: President and Chief
Financial Officer

		
	By:	 	 
		 	 Name: Eric R. Ball
 Title: Vice President and
Treasurer

 This is one of the Notes of the series designated herein and referred to in the within-mentioned
Indenture. 
 Dated: April 9, 2008 
  

			
	 The Bank of New York Trust Company, N.A.,
     as Trustee

		
	By:	 	 
		 	Authorized Signatory

 (REVERSE OF NOTE) 
 ORACLE CORPORATION 
 6.500% Notes due 2038 
  

	 	1.	Interest. 

 Oracle Corporation (the
“Issuer”) promises to pay interest on the principal amount of this Note at the rate per annum described above. Cash interest on the Notes will accrue from the most recent date to which interest has been paid; or, if no interest has
been paid from April 9, 2008. Interest on this Note will be paid to but excluding the relevant Interest Payment Date. The Issuer will pay interest semi-annually in arrears on each Interest Payment Date, commencing October 15, 2008.
Interest will be computed on the basis of a 360-day year consisting of twelve 30-day months in a manner consistent with Rule 11620(b) of the NASD Uniform Practice Code. 
 The Issuer shall pay interest on overdue principal from time to time on demand at the rate borne by the Notes and on overdue installments of interest (without regard to any applicable grace periods) to the extent
lawful. 
  

	 	2.	Paying Agent. 

 Initially, The Bank of New York Trust
Company, N.A. (the “Trustee”) will act as paying agent. The Issuer may change any paying agent without notice to the Holders. 
  

	 	3.	Indenture; Defined Terms. 

 This Note is one of the 6.500%
Notes due 2038 (the “Notes”) issued under an indenture dated as of January 13, 2006 (the “Base Indenture”) by and among the Issuer (formerly known as Ozark Holding Inc.), Oracle Systems Corporation (formerly
known as Oracle Corporation) and Citibank, N.A., as amended by a supplemental indenture dated as of May 9, 2007 (together with the Base Indenture, the “Indenture”) by and among the Issuer, Citibank, N.A. and the Trustee, and
established pursuant to an Officers’ Certificate dated April 9, 2008, issued pursuant to Section 2.01 and Section 2.03 thereof (together, the “Indenture”). This Note is a “Security” and the Notes are
“Securities” under the Indenture. 

 For purposes of this Note, unless otherwise defined herein, capitalized terms herein are used as defined
in the Indenture. The terms of the Notes include those stated in the Indenture and those made part of the Indenture by reference to the Trust Indenture Act of 1939 (15 U.S.C. Sections 77aaa-77bbbb) (the “TIA”) as in effect on the
date on which the Indenture was qualified under the TIA. Notwithstanding anything to the contrary herein, the Notes are subject to all such terms, and holders of Notes are referred to the Indenture and the TIA for a statement of them. To the extent
the terms of the Indenture and this Note are inconsistent, the terms of the Indenture shall govern. 
  

	 	4.	Denominations; Transfer; Exchange. 

 The Notes are in
registered form, without coupons, in denominations of $2,000 and multiples of $1,000 thereafter. A Holder shall register the transfer or exchange of Notes in accordance with the Indenture. The Issuer may require a Holder, among other things, to
furnish appropriate endorsements and transfer documents and to pay certain transfer taxes or similar governmental charges payable in connection therewith as permitted by the Indenture. The Issuer need not issue, authenticate, register the transfer
of or exchange any Notes or portions thereof for a period of fifteen (15) days before the mailing of a notice of redemption, nor need the Issuer register the transfer or exchange of any Note selected for redemption in whole or in part.

  

	 	5.	Amendment; Supplement; Waiver. 

 Subject to certain
exceptions, the Notes and the provisions of the Indenture relating to the Notes may be amended or supplemented and any existing default or Event of Default or compliance with certain provisions may be waived with the written consent of the Holders
of at least a majority in aggregate principal amount of all series of Outstanding Securities (including the Notes) under the Indenture that are affected by such amendment, supplement or waiver (voting as a single class). Without notice to or consent
of any Holder, the parties thereto may amend or supplement the Indenture and the Notes to, among other things, cure any ambiguity, defect or inconsistency or comply with any requirements of the Commission in connection with the qualification of the
Indenture under the TIA, or make any other change that does not adversely affect the rights of any Holder of a Note. 
  

	 	6.	Redemption. 

 The Issuer may at its option redeem any of
the Notes in whole or in part at any time, each at a redemption price calculated by the Issuer equal to the greater of: 
 (i) 100% of the
principal amount of the Notes to be redeemed; and 

 (ii) the sum of the present values of the remaining scheduled payments of principal and interest thereon
(not including any portion of such payments of interest accrued as of the date of redemption), discounted to the date of redemption on a semi-annual basis (assuming a 360-day year consisting of twelve 30-day months) at the Treasury Rate (as defined
below) plus 35 basis points, plus in each case accrued interest thereon to the date of redemption. 
 Notwithstanding the foregoing,
installments of interest on Notes that are due and payable on interest payment dates falling on or prior to a redemption date will be payable on the interest payment date to the registered Holders as of the close of business on the relevant record
date according to the Notes and the Indenture. 
 “Comparable Treasury Issue” means the United States Treasury security
selected by the Quotation Agent as having a maturity comparable to the remaining term of the Notes to be redeemed that would be utilized, at the time of selection and in accordance with customary financial practice, in pricing new issues of
corporate debt securities of comparable maturity to the remaining term of the Notes. 
 “Comparable Treasury Price” means,
with respect to any redemption date, (i) the average of four Reference Treasury Dealer Quotations for such redemption date, after excluding the highest and lowest such Reference Treasury Dealer Quotations, or (ii) if the Quotation Agent
obtains fewer than four such Reference Treasury Dealer Quotations, the average of all such quotations, or (iii) if only one Reference Treasury Dealer Quotation is received, such quotation. 
 “Quotation Agent” means the Reference Treasury Dealer appointed by the Issuer. 
 “Reference Treasury Dealer” means (i) Citigroup Global Markets Inc., Credit Suisse Securities (USA) LLC or Morgan
Stanley & Co. Incorporated (or their respective affiliates that are Primary Treasury Dealers) and their respective successors; provided, however, that if any of the foregoing shall cease to be a primary U.S. Government
securities dealer in New York City (a “Primary Treasury Dealer”), the Issuer will substitute therefor another Primary Treasury Dealer, and (ii) any other Primary Treasury Dealer selected by the Issuer. 
 “Reference Treasury Dealer Quotations” means, with respect to each Reference Treasury Dealer and any redemption date, the average, as
determined by the Quotation Agent, of the bid and asked prices for the Comparable Treasury Issue (expressed in each case as a percentage of its principal amount) quoted in writing to the Quotation Agent by such Reference Treasury Dealer at 5:00
p.m., New York City time, on the third business day preceding such redemption date. 

 “Treasury Rate” means, with respect to any redemption date, the rate per annum equal to
the semi-annual equivalent yield to maturity of the Comparable Treasury Issue, assuming a price for the Comparable Treasury Issue (expressed as a percentage of its principal amount) equal to the Comparable Treasury Price for such redemption date.

 Notice of any redemption will be mailed at least 30 days but not more than 60 days before the redemption date to each Holder of
the Notes to be redeemed. Unless the Issuer defaults in payment of the redemption price, on and after the redemption date, interest will cease to accrue on the Notes or portions thereof called for redemption. If less than all of the Notes are to be
redeemed, the Notes to be redeemed shall be selected by lot by the Depositary, in the case of Notes represented by a Global Note, or by the Trustee by a method the Trustee deems to be fair and appropriate, in the case of Notes that are not
represented by a Global Note. 
  

	 	7.	Defaults and Remedies. 

 If an Event of Default (other than
certain bankruptcy Events of Default with respect to the Issuer) under the Indenture occurs with respect to the Notes and is continuing, then the Trustee may and, at the direction of the Holders of at least 25% in principal amount of the outstanding
Notes, shall by written notice, require the Issuer to repay immediately the entire principal amount of the Outstanding Notes, together with all accrued and unpaid interest and premium, if any. If a bankruptcy Event of Default with respect to the
Issuer occurs and is continuing, then the entire principal amount of the Outstanding Notes will automatically become due immediately and payable without any declaration or other act on the part of the Trustee or any Holder. Holders of Notes may not
enforce the Indenture or the Notes except as provided in the Indenture. The Trustee is not obligated to enforce the Indenture or the Notes unless it has received indemnity as it reasonably requires. The Indenture permits, subject to certain
limitations therein provided, Holders of a majority in aggregate principal amount of the Notes then outstanding to direct the Trustee in its exercise of any trust or power. The Trustee may withhold from Holders of Notes notice of certain continuing
defaults or Events of Default if it determines that withholding notice is in their interest. 
  

	 	8.	Authentication. 

 This Note shall not be valid until the
Trustee manually signs the certificate of authentication on this Note. 
  

	 	9.	Abbreviations and Defined Terms. 

 Customary abbreviations
may be used in the name of a Holder of a Note or an assignee, such as: TEN COM (= tenants in common), TEN ENT (= tenants by the entireties), JT TEN (= joint tenants with right of survivorship and not as tenants in common), CUST (= Custodian),
and U/G/M/A (= Uniform Gifts to Minors Act). 

	 	10.	CUSIP Numbers. 

 Pursuant to a recommendation promulgated
by the Committee on Uniform Security Identification Procedures, the Issuer has caused CUSIP numbers to be printed on the Notes as a convenience to the Holders of the Notes. No representation is made as to the accuracy of such numbers as printed on
the Notes and reliance may be placed only on the other identification numbers printed hereon. 
  

	 	11.	Governing Law. 

 The laws of the State of New York shall
govern the Indenture and this Note thereof. 

 ASSIGNMENT FORM 
 To assign this Note, fill in the form below: 
 I or we assign and transfer this Note to 
  

					
		  	(Print or type assignee’s name, address and zip code)	  	
			
		  	(Insert assignee’s soc. sec. or tax I.D. No.)	  	

 and irrevocably appoint
                            agent to transfer this Note on the books of the Issuer. The agent may substitute
another to act for him. 
  

									
					
	 	  	 	  	 	  	 	  	 
					
		  		  		  		  	
					
	 Date:
	  	 	  	Your Signature:	  	 	  	
					
		  		  		  		  	
					
	 	  	 	  	 	  	 	  	 
	
	Sign exactly as your name appears on the other side of this Note.

  

					
			
	 	 		 	  
		 		 	Signature
	Signature Guarantee:	 		 	
			
	  	 		 	  
	Signature must be guaranteed	 		 	Signature

 Signatures must be guaranteed by an “eligible guarantor institution” meeting the
requirements of the Registrar, which requirements include membership or participation in the Security Transfer Agent Medallion Program (“STAMP”) or such other “signature guarantee program” as may be determined by the
Registrar in addition to, or in substitution for, STAMP, all in accordance with the United States Securities Exchange Act of 1934, as amended. 

 SCHEDULE OF EXCHANGES OF NOTES 
 The following exchanges of a part of this Global Note for Physical Notes or a part of another Global Note have been made: 
  

									
	 Date of Exchange
	  	Amount of decrease
in principal amount
of this Global Note	  	Amount of increase
in principal amount
of this Global Note	  	Principal amount of
this Global Note
following such
decrease (or
increase)	  	Signature of
authorized officer of
Trustee

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00140-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00140-of-00352.parquet"}]]